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Malaria, one of the world's most deadly and infamous diseases, has a dynamic 
in-host ecology which heavily shapes its evolution. However, determining the 
epidemiological relevance of malaria in-host ecology has been hindered by an 
incomplete understanding of how it relates to the essential life history ingredient: 
reproduction and between-host transmission. This lack of knowledge has potentially 
contributed to the ongoing failure to eradicate the disease. In this doctoral thesis I 
attempted to begin unraveling the mysterious relationship between malaria in-host 
ecology and transmission to provide insights into effective disease control strategies. 
My research was conducted using the rodent malaria parasite Plasmodium 
chabaudi, which proves to be a highly malleable experimental and laboratory model for 
its human counterpart, Plasmodiumfalciparum. The initial phases of the work required 
the development of new methods to more accurately investigate malaria transmission. I 
harnessed the wealth of growing malaria molecular information, and developed a novel 
quantitative reverse transcription PCR technique (qRT-PCR) for clone specific 
assessment of P. chabaudi transmission stage production. I combined the qRT-PCR 
technique with current qPCR methods for quantification of in-host total parasite 
numbers, to examine in-host replication and transmission investment strategies in 
relation to infection stage, conspecific interactions, and drug resistance evolution. 
This detailed life history investigation revealed that the majority of malaria total 
parasite and transmission stage production occurs within the initial phase of infection. 
However, many individuals develop very low level long lasting chronic infections which 
are transmissible to vectors and likely to heavily impact the epidemiology of the parasite, 
confirming current findings in the field. 
During the high parasite density stage at the start of the infection, in-host 
dynamics and conspecific competition were found to play a critical role in shaping the 
fitness of malaria genotypes co-infecting the same host. In response to conspecific 
competition, a small degree of transmission investment plasticity was observed, but this 
did not affect the competitive outcome. 
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In-host competition dynamics were greatly influenced by drug treatment, when 
drug resistant and sensitive genotypes co-infected the same host. In this case, it was 
observed that strong drug dosage, which completely cleared the drug sensitive clone, 
released the resistant clone from competition, resulting in its enhanced growth and 
increased transmission potential. Reducing drug dosage to levels that did not completely 
clear the sensitive genotype, still enabled the resistant clone to be released from 
competition, but prevented its enhanced growth. Thus, drug dosages, which just 
alleviate clinical symptoms but do not completely clear parasites, will preserve within 
host competition and may reduce the rate at which drug resistance spreads. This 
contradicts current medical thinking that incomplete drug treatment regimes will 
accelerate drug resistance evolution. 
In conclusion, this doctoral thesis reinforces that a deeper understanding of the 
relationship between in-host ecology and transmission will enhance our ability to 
unravel the evolutionary dynamics of malaria and conquer the summit of global disease 
eradication. 
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Darwin revealed that those individuals which are the most reproductive and 
produce the greatest number of viable offspring will pass on their traits, thereby 
obtaining the highest levels of fitness, thus driving evolution (Darwin 1859). Those who 
fail to reproduce, in essence, reach the end of their family tree, leaving their genes 
behind to be forgotten for the rest of evolutionary time. 
" ...individuals having any advantage, however slight, over others, would have 
the best chance of surviving and of procreating their kind? On the other hand, we may 
feel sure that any variation in the least degree injurious would be rigidly destroyed. This 
preservation of favourable variations and the rejection of injurious variations, I call 
Natural Selection..." (Darwin 1859). 
Like all organisms, parasite fitness and evolution is driven by reproduction. In 
the parasite's case, reproduction is closely intertwined with transmission from one host 
to the next. Although a parasite may spend a lifetime reeking havoc in the one traveler 
who mistakenly 'thought it was ok to drink the water', eventually that traveler will die, 
and ultimately the parasite's fitness depends on sending its progeny out into the world to 
find a new host. 
Amazingly, despite all its conceptual simplicity and importance, the reproduction 
and transmission of many parasites remains sparsely investigated and poorly understood. 
In fact, the majority of parasite research has focused on more cellular functional biology 
type questions, like 'what genes do what' and 'how do they get turned off or on'. This 
approach has clearly been hugely rewarding in the field of drug discovery and vaccine 
research, as well as exposed a wealth of important parasite biology. However, it cannot 
explain the evolutionary ecological reason genes are maintained and passed on. In 
reality, parasites can be particularly shy when revealing their reproductive transmission 
habits. Here, I attempted to 'pull back the curtains' a bit to dissect the important role 
reproduction plays in shaping the evolution of one of the world's most deadly parasites, 
malaria. 
1.1. Malaria epidemiology: a global problem 
Malaria is one of the ten deadliest global diseases currently infecting mankind, 
killing over a million people each year and causing economic burden and morbidity for 
an estimated half a billion more (Breman 2001; Snow et al. 2005). Approximately one 
third of the world's population is at risk of malaria infection, with the disease being most 
prevalent in Africa, South America, and South East Asia, where inadequate health care, 
high poverty, and optimal vector breeding conditions all contribute to the persistence of 
the parasite (Lopez et al. 2006). The majority of clinical malaria cases and deaths occur 
in children, who are believed to be most susceptible to the disease due to a lack of 
developed immunity (Githeko et al. 1992; Kolk et al. 2003). Acquired immunity to 
malaria is typically relatively weak and the illness is very common in adults living in 
endemic malaria regions, who often develop asymptomatic infections; however, fever, 
coma, and death also regularly occur (Drakeley et al. 2000; Breman 2001). 
The regional burden of malaria fluctuates substantially both on a temporal and 
spatial scale (Hay et al. 2000; Snow et al. 2005), with many areas having regular 
seasonal patterns of parasite prevalence and transmission (James 1931; Roper et al. 1998; 
Kolk et al. 2003; Shililu et al. 2003; Nacher et al. 2004; Paul et al. 2004a). This 
seasonality is primarily driven by rainfall which regulates the mosquito vector 
population (Grover-Kopec et al. 2006). The African continent is particularly well 
known for annual cycles of rainy seasons with high mosquito densities, separated by dry 
periods with low vector abundance. Just prior to the onset of the rainy season parasite 
prevalence and parasitemia of infected individuals, are typically very low (Hamad et al. 
2002). As the rain falls, vectors become more populous and parasitemia rises, due to 
novel infections or stimulated parasite production from mosquito biting. This ultimately 
results in increased transmission and elevated disease prevalence (Paul et al. 2004a). In 
areas where transmission seasons are separated by very lengthy dry seasons, individuals 
can develop very low level infections lasting for several months (Babiker et al. 1998; 
Hamad et al. 2000). It is believed that in some cases, long transmission free periods 
result in a degree of immunity loss in the population, generating small epidemics when 
the rainy season arrives (Druilhe and Perignon 1997; Worrall et al. 2004). 
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1.2. Control failure 
Malaria control efforts have been under way for well over a century and 
originally culminated in high success with the eradication of the disease from parts of 
Europe and the Americas in the early 1900's, mainly driven by environmental 
management (Keiser et al. 2005). In recent years control has proven more difficult, 
primarily due to the evolution of drug resistance by the parasite and insecticide 
resistance in vectors, resulting in a resurgence of the disease after the implementation of 
chemical treatment strategies (Campbell 1997; Sachs 2002; Guinovart et al. 2006). 
Drug treatment of malaria formally began sometime in the 17 0' century with the 
advent of quinine, the active ingredient of the chinchona plant which had been used by 
South Americans for centuries before. By the 20 th century resistance of malaria to the 
drug was documented which, compounded with the high cost and undesirable side 
effects of quinine, led to the design of new safer and more effective compounds, such as 
chloroquine, towards the end of the Second World War. Resistance to chioroquine, 
spread within almost a decade, leading to the development of a host of new drug 
treatments, to almost all of which resistance rapidly evolved (Hyde 2005). 
To counteract the effects of anti-malarial drugs, parasites have evolved unique 
genetic resistance mechanisms (Reed et al. 2000). Resistance to chloroquine for 
example, is believed to be due to a mutation in the chioroquine resistance transporter 
gene (pfcrt), which allows the parasite to use a pump mechanism to clear the drug 
(Fidock et al. 2000; Sidhu et al. 2002). Similarly, resistance to the common anti-
malarial antifolate treatment pyrimethamine, is believed to be incurred by mutations in 
dihydrofolate reductase (dhfr), and mutations in the dihydropteroate synthetase (dhps) 
gene can lead to further resistance to other antifolates like sulfadoxine. Both the dhfr 
and dhps mutations are believed to incur resistance by preventing the drug from binding 
to its appropriate receptor (Peterson et al. 1990; Sibley et al. 2001). 
Drug resistance did not come freely to the parasite. All drug resistance 
mutations require the parasite to utilize vital resources for drug clearance rather than 
growth or reproduction and therefore, they are likely to come at an energetic and fitness 
cost (Walliker et al. 2005). The level of this fitness cost is believed to vary widely 
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depending on the mechanism of drug activity and the number of mutations the parasite 
requires for evasion. This can have important consequences for how quickly resistance 
will evolve (Hastings 2004). For example, chioroquine pfcrt resistance requires several 
mutations and evolved relatively slowly, on the scale of a decade or more. 
Alternatively dhfr resistance only requires a single point mutation, partly explaining its 
rapid evolution after a few years of first administration in the field (Canton etal. 2001; 
Hastings and Donnelly 2005). A slew of other epidemiological factors, such as the 
degree of drug usage in the community, parasite recombination, host immunity, intra-
host dynamics, duration of drug efficacy in the host, and transmission intensity, are also 
all predicted to play a critical role in shaping resistance evolution. Ultimately, this has 
made it difficult to obtain a complete understanding of the relationship between 
resistance fitness costs and the rate of evolution (Hastings 1997; Hastings et al. 2002; 
Hastings 2003; Talisuna et at. 2003; Hastings and Watkins 2005; Hastings 2006). 
Although theoretical literature has provided us with a wealth of ideas, very little 
is known empirically about the ecological mechanisms and fitness dynamics underlying 
drug resistance evolution. Furthermore, it is becoming increasingly clear that achieving 
efficient and effective malaria control requires a deeper understanding of the basic 
evolutionary ecology of the parasite (De Roode and Read 2003; Paul et at. 2003; 
Molyneux 2006). Several avenues of parasite control have been attempted in the wake 
of drug resistance, such as insecticide treatment and vaccine development, and they have 
all met poor degrees of success, in many ways due to an oversight of basic ecological 
principles (Wellems 2002; Greenwood 2005; Targett 2005). Some of their failures have 
been, simply put, down right embarrassing, particularly the widespread DDT resistance 
resulting from the 'global malaria eradication campaign', which could have easily been 
predicted by evolutionary ecologists. I assert that the newest control strategies which 
have the most promise are those that have attempted to incorporate parasite ecology into 
their development (Blanford et al. 2005). With the increasing prospect of a malaria 
vaccine, an understanding of the evolutionary ecology of the malaria is more critical 
than ever, especially when we consider that some control strategies could do more harm 
than good (Gandon et at. 2001). 
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1.3.1. A complex life history 
At least four species of malaria regularly circulate in humans (Plasmodium vivax, 
P. malaria, P. ovale, and P. falciparum) with P. falciparum contributing to the majority 
of clinical cases and mortality (Breman 2001). Plasmodium is a protozoan parasite in 
the phylum Apicomplexa which includes an array of parasitic genera such as Babesia, 
Cryptosporidia, and Toxoplasma, all commonly infecting humans. The haemosporidian 
malarial parasite family of Plasmodiidae is extremely diverse and species are regularly 
found residing in birds, mammals and reptiles. The human malaria P. falciparum and its 
close relative P. reichenowi in chimpanzees appear to be uniquely separated from the 
other haemosporidian parasites in mammals, suggesting a long evolutionary branching 
(Perkins and Schall 2002). 
Despite their sometimes highly divergent evolutionary past, all Plasmodium have 
a very similar life cycle divided into asexual and sexual replication (Figure 1.1). In the 
vertebrate host the parasite life cycle begins as a haploid sporozoite transmitted by an 
insect vector, which in the case of P. falciparum is commonly a mosquito in the genus 
Anopheles (Kiszewski et al. 2004). Upon entering the host, sporozoites travel to the 
liver where they undergo mitosis, releasing thousands of merozoites. These merozoites 
then infect red blood cells to enter an asexual replication cycle and develop into ring 
stages, trophozoites and then schizonts. Schizonts burst red bloods cells releasing 
between 4-20 merozoites, depending on the species, which go on to re-infect other red 
blood cells and continue the cycle of asexual replication (Vickerman 2005). In many 
malaria species this asexual cycle is very synchronous, typically resulting in regular 
fever spikes in patients as red blood cells rupture (James 1931). 
During the asexual replication cycle a small percentage of merozoites become 
committed to development into sexual stage gametocytes (Talman et al. 2004). 
Gametocytes in P. falciparum usually comprise less than 5% of the in-host parasite 
population (Taylor and Read 1997); however, they are of vital importance to the parasite 
as they are the only stage transmitted to the mosquito vector during a blood meal. Once 
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inside the mosquito midgut, male gametocytes exflagellate and release up to 8 
microgametes, which then fertilize the female macrogamete. During this diploid stage, 
recombination can occur as the parasite develops into an ookinete, which penetrates the 
mosquito gut wall and develops into an oocyst. The oocyst takes approximately 14 days 
to mature during which time it undergoes meiosis and several rounds of mitosis, to 
release tens of thousands of haploid sporozoites that travel into the mosquito salivary 
glands for transmission to a new host during blood feeding (Garnham 1966). 
The development from one life stage to the next in Plasmodium is often 
characterized by the up and down regulation of specific genes. Many of these genes are 
uniquely expressed in only one life stage, particularly those found in gametocytes (Cui 
et al. 2001; van Dijk et at. 2001; Kongkasuriyachai et at. 2004; Gardiner et at. 2005; 
Hall et at. 2005; Silvestrini et at. 2005; Young et at. 2005). Much of this information 
regarding gene specificity has been elucidated only recently, coming to light after the 
completion of the genome-wide malaria sequence (Canton et at. 2002; Gardner et at. 
2002). The knowledge of unique life stage gene expression can now be utilized to 
identify, detect, and even purify individual life stages, by targeting specific RNA or 
protein transcripts (Florens et at. 2002; Lasonder et at. 2002; Khan et at. 2005). This 
has led to huge advances in the field, resulting not only in a deeper understanding of the 
fundamental biology of the parasite, but also the ability to create new drug and vaccine 
candidates (Kongkasuriyachai and Kumar 2002). From an ecological prospective, it can 
provide us with powerful tools for studies of parasite life history strategies and their 
epidemiological impact. 
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Figure 1.1. Malaria life-cycle in mammals, in this case humans, reprinted from Center 
for Disease Control website (CDC 2006). 
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1.3.2. An undetected pest 
Malaria parasite densities in the host usually peak within the first week or two 
after transmission, in what is known as the acute phase, and then trail off as the host 
controls the infection (Garnham 1954). Subsequently, recrudescent waves in parasite 
density can occur, with the infection often persisting for several months to years, in what 
is termed the chronic phase (James 1931; Jeffery and Eyles 1955; Druilhe and Perignon 
1997; Hamad et al. 2000). During intervals between recrudescent peaks, parasites are 
frequently undetectable in the blood stream and are believed to be sequestered in host 
organs such as the liver (Landau et al. 1999; Vardo et al. 2005; Wargo et al. 2006). This 
sequestering phenomenon is common in many mammalian malaria species including P. 
falciparum. 
The classical approach for diagnosis of malaria infection has been microscopic 
scanning of thick blood smears to determine both species and infection status. Due to 
the low parasite densities which commonly occur in malaria infections, individuals have 
often been misdiagnosed as uninfected (Roper et at. 1996; Babiker et al. 1999a; 
Awadalla et al. 2001). As a result, new more sensitive approaches for parasite detection 
were developed. The most widely implemented approach has been PCR amplification 
of parasite DNA. This method has many benefits for field research, most notably, its 
ease of use and low cost. Due to the very recent advent of sensitive molecular detection 
techniques, the importance of low level infections in the host has been largely 
uninvestigated. However, it is becoming increasingly clear that they may play a critical 
role in the epidemiology of the parasite, particularly in areas of long lasting low level 
infections (Bottius et al. 1996; Hamad et al. 2002; Bousema et al. 2006; Schneider et al. 
2006) (see Chapter 2 and 3). We now have the ability to not only detect, but also begin 
quantifying transmission from these types of low level infections. 
1 .3.3. Hidden diversity 
Another major advancement provided with molecular technologies was the 
ability to infer parasite genetic diversity. Although genetic diversity work began many 
years before using enzyme markers (Walliker et al. 1972; Carter and McGregor 1973), it 
was greatly enhanced by the implementation of PCR. These studies ultimately 
confirmed that malaria infections are commonly highly genetically diverse, especially P. 
falciparum, with individual hosts typically harboring several distinct alleles, i.e. multi-
locus genotypes (Babiker and Walliker 1997; Druilhe et al. 1998; Anderson et al. 2000; 
Farnert et al. 2001; Magesa et al. 2002; Jafari et al. 2004). Due to the haploid and 
clonal asexual replicating nature of the parasite within the vertebrate host, these 
genotypes are often referred to as clones. Multiplicity of infection (clones/host) appears 
to be highest in areas of intense transmission, but is recorded world wide (Arnot 1998; 
Babiker et al. 1999b). This is especially true when considering that PCR underestimates 
the degree of genetic diversity, due to limits in the types of detectable genetic variation 
and the tendency to only amplify the most abundant genotypes (Hill et al. 1995; Babiker 
et al. 1997; Druilhe et al. 1998; Ofosu-Okyere et al. 2001; Abdel-Muhsin et al. 2002). 
The limitations of PCR are likely to be circumvented by the development of new 
quantitative PCR technologies, which make it possible not only to differentiate clones 
based on as little as two or three point mutations in genetic material, but also provide an 
accurate method to quantify the parasitemia of individual clones in mixed infections 
(Bell et al. In Press). Quantitative PCR technologies are now being further combined 
with the new information on life cycle variation in gene expression, to develop in-host 
stage specific quantification (Babiker et al. 1999a; Bruna-Romero et al. 2001; Witney et 
al. 2001; Schneider et al. 2004; Wargo et al. 2006) (see Chapter 2). These technologies 
have finally made it possible to examine the interactions and dynamics of individual 
clones co-infecting a single host, which previously remained sparsely investigated due to 
the high labor intensity of the mono-clonal antibody techniques required (Taylor et al. 
1997b; Bell and Ranford-Cartwright 2002). 
1.3.4. The ecology of mixed infections: competition has its hay-day 
The discovery of high genetic diversity in malaria and the new genotype specific 
quantification molecular technologies rapidly brought to question what role genetic 
diversity plays in shaping the epidemiology of the parasite (Awadalla et at. 2001; Read 
and Taylor 2001). Most notably, how clones interact in the host is likely to heavily 
influence the evolution of the disease. For instance, epidemiological studies from the 
field suggest that in-host ecology and competition between clones, are the probable 
driving forces behind the displacement of genotypes from certain geographical areas 
(Daubersies et al. 1996; Mercereau-Puijalon 1996; Arnot 1998). These findings have 
been further supported in the last ten years by the strong competition dynamics observed 
in mixed clone infections of the rodent malaria Plasmodium chabaudi, the research of 
which was greatly enhanced by clone specific parasite density quantification 
technologies (Taylor et al. 1997a; Taylor et at. 1997b; Taylor et al. 1998; Taylor and 
Read 1998; De Roode et at. 2003; De Roode et al. 2004a; De Roode et at. 2004b; De 
Roode et al. 2005a; Bell et at. In Press). 
Due to its likely high prevalence in the field, conspecific competition is now 
believed to heavily shape the degree of disease severity the parasite causes to its host, i.e. 
virulence. For many years theoretical work has ascertained that in-host competition 
should select for rapidly replicating genotypes, which will have higher transmission 
success and fitness than their competitors. Since in-host replication is also believed to 
be correlated with parasite virulence, the evolution of higher virulence is predicted as a 
by product of competition (van Baalen and Sabelis 1995; Frank 1996; Mosquera and 
Adler 1998; Amarasekare and Nisbet 2001; Brown et al. 2002; Mackinnon et al. 2002a; 
Paul et al. 2004b). Intra-specific competition experiments with P. chabaudi have 
recently demonstrated that a positive relationship between virulence and competitive 
ability is indeed present (De Roode et al. 2005b; Bell et al. In Press). 
The growing experimental support for conspecific competition has also had a 
large impact on theories of drug resistance evolution, which is now thought to be heavily 
shaped by intra-host dynamics (Hastings and D'Alessandro 2000). The high genetic 
diversity observed in malaria provides strong evidence that drug resistant and sensitive 
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genotypes will regularly circulate in the same host. In the face of in-host conspecific 
competition, resistant genotypes are believed to be competitively inferior in the absence 
of drug treatment, due to the fitness cost that resistance incurs, and there is some 
experimental evidence that this is true (De Roode et al. 2004a; Walliker et al. 2005). 
The level to which drug treatment alleviates the resistance fitness cost, and the degree of 
competitive superiority the resistant genotype obtains, will play a particularly critical 
role in shaping the rate of drug resistance evolution (Hastings 2006). Unraveling this 
dynamic has been cited as one of the most important factors in understanding the 
evolution of drug resistance (Hastings and D'Allessandro 2000). Experimental 
investigation into this subject is, to my knowledge very limited, especially when 
considering competition dynamics in response to differing drug treatment strategies (see 
Chapter 5). 
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1.3.5. The missing link: transmission 
The importance of malaria ecology in shaping the evolution of the parasite is 
becoming increasingly clear. In particular, in-host ecology is now believed to be a key 
player in parasite epidemiology (Daubersies et al. 1996; Mercereau-Puijalon 1996; 
Arnot 1998; Read and Taylor 2001; Paul et al. 2004b; De Roode et al. 2005b; Bell et al. 
In Press). However, one very important piece to the puzzle is still missing: transmission. 
Surprisingly, this is also the one piece with the most relevance. From a purely 
Darwinian population biology perspective, it is the frequency of alleles in the population 
that really matter, and transmission to new hosts that will ultimately shape lifetime 
fitness and evolution. This does of course bring to mind the obvious question: can 
transmission be predicted from observed in-host dynamics? Simply put, we do not have 
enough evidence to conclude either way. 
We do know that genetic variation in transmission life history traits exists 
(Mackinnon and Read 1999a; Eisen and Schall 2000). There is also strong experimental 
evidence that transmission dynamics can be shaped by an array of environmental factors 
including drug treatment, host anemia, and immunity; through alterations in gametocyte 
production timing, density, and sex-ratio (Gautret et al. 1996b; Buckling et al. 1999c; 
Price etal. 1999; Paul et al. 2000; Buckling and Read 2001; Paul etal. 2002a; Paul et al. 
2003; Paul and Brey 2003; Reece et al. 2005). Parasite influence on vector behavior has 
even been observed (Rossignol et at. 1986; Koella et al. 2002; Ferguson and Read 2004). 
It seems logical to assume that malaria parasites will exhibit similar transmission 
adaptive responses to competition. Inter-specific competition leading to reduced 
transmission of the avian malaria Plasmodium gallinaceum from hosts co-infected with 
Plasmodiumjuxtanucleare has been observed experimentally (Paul et al. 2002b). 
Further evidence from field data also suggests that between species competition is likely 
to shape the transmission and epidemiology of human malaria, and one study found 
enhanced P. falciparum gametocyte production in competition with P. malariae 
(McKenzie and Bossert 1997; Bruce et at. 2000; McKenzie et al. 2002; Mayxay et al. 
2004). 
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Transmission dynamics of individual clones during conspecific competition are 
less clear and the interactions are likely to be very different to those occurring between 
separate parasite species. Local mate competition theory predicts that gametocyte sex-
ratio variation should regularly occur during conspecific competition, with greater male 
gametocyte production as clonal diversity increases (Read et al. 1992). Generally the 
theory holds true for Plasmodium (Read et al. 1995; West et al. 2001), although to my 
knowledge the sex ratio investment of individual clones during conspecific competition 
has not been assessed. Ultimately, gametocyte sex ratio is likely to heavily impact 
transmission success depending on how it affects overall fertility (Schall 2000; West et 
al. 2002). 
Mixed genotype infections of P. chabaudi have shown some evidence of 
increased transmission during conspecific competition, although an alternative study 
found no changes in transmission, this dichotomy likely reflecting the different clones 
examined (Taylor et al. 1997a; De Roode et al. 2005b). Neither of these studies 
examined the transmission response of individual malaria clones explicitly, which to my 
knowledge remains uninvestigated. Using new quantitative molecular methods it is now 
possible to analyze clone specific investment towards transmission. This sort of 
investigation could potentially play a critical role in bridging the gap between in-host 
dynamics, transmission, and ultimately, epidemiology (Chapter 4). 
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1.4. A note on rodent malaria as a model system 
Addressing the relationship between parasite in-host ecology and transmission 
ultimately demands detailed experimental investigation, where clonal diversity can be 
experimentally controlled. Due to the testing and development of new technologies 
necessary, this line of inquiry proves both ethically and logistically impractical in the 
natural human host. Therefore an experimental model system is required. Although in 
vitro experimental studies are feasible, the host's effect on dynamics is an important 
factor for parasite evolution (Gupta and Anderson 1999). All experimental work in this 
thesis was therefore conducted using the rodent malaria parasite Plasmodium chabaudi. 
There are many similarities between P. falciparum and P. chabaudi that make 
the rodent malaria species a particularly good model system. From a clinical disease 
perspective, both parasites cause severe anemia and rosetting of host red blood cells 
which likely contribute to host morbidity (Udomsangpetch et al. 1989; Mackinnon et al. 
2002b). The life cycles of both parasite species are also very congruent, signified by an 
initial acute phase of high parasitemia followed by long lasting chronic infections with 
recrudescent waves of parasites (James 1931; Garnham 1954; Jeffery and Eyles 1955; 
Garnham 1966; Druilhe and Perignon 1997; Hamad etal. 2000; Kolk et al. 2003; Wargo 
et al. 2006). Evolutionarily, genome similarity between human and rodent malaria 
species is extensive (Janse etal. 1994; Carlton etal. 1998; Thompson etal. 2001; 
Carlton et al. 2002; Waters 2002). Additionally, both parasites exhibit high levels of 
genetic diversity in the field with mixed genotype infections regularly occurring in the 
host (Carter and Walliker 1975; Awadalla et al. 2001). 
A particular benefit to utilizing P. chabaudi as an experimental system is the 
ability to experimentally induce controlled infections composed of multiple clones. A 
stockpile of several unique P. chabaudi clones is currently available, with each clone 
having been maintained as a distinct genetic line with a well documented history, since 
its collection from the natural thicket rat host (Thamnomys rutilans) in the field (Beale et 
al. 1978). 
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Furthermore, drug resistant and sensitive P. chabaudi clones are accessible, 
possessing the same genetic mutations as those occurring in P. falciparum (Canton et al. 
2001). Therefore, it is possible to examine the fitness of drug resistant clones in relation 
to drug sensitive clones. Ultimately, P. chabaudi has frequently been utilized as a model 
for P. falciparum and its merits as a candidate for this type of comparison are well 
validated (Mackinnon and Read 2004). However, since it is a model system, certain 
limitations do apply, depending on the type of questions examined and comparisons 
made. The specific limitations of the P. chabaudi system, as they directly relate to the 
research and findings of my doctoral thesis, are discussed in more detail in section 6.4. 
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1.5. Experimental Aims 
The overall objective of this thesis was to fill in the gap in our understanding of 
the relationship between in-host malaria ecology and transmission dynamics. Each 
chapter was written as an independent unit for publication, with its own introduction 
placing it in the broad context of malaria evolutionary ecology, and therefore I will 
avoid reiteration here. In summary, my first aim was to develop an accurate clone 
differentiating method for selective quantification of malaria parasite transmission stages. 
I then hoped to implement this technique to assess the impact of critical epidemiological 
phenomenon, such as long lasting infections, conspecific competition, and drug 
resistance, on the transmission dynamics and evolution of malaria. Ultimately this 
research strived to enhance our understanding of malaria evolutionary ecology and 
provide insights into effective disease control strategies. 
Specific questions: 
Can low level chronic infections in the host transmit to the mosquito vector, and if so, 
what is their epidemiological impact (Chapter 2 and 3)? 
Does within-host competition influence the transmission dynamics of individual clones 
and what consequences will this have for the evolution of virulence (Chapter 4)? 
How does the competition dynamic between drug resistant and sensitive clones depend 
on drug treatment regime and what role does this play in shaping the transmission and 
evolution of drug resistance (Chapter 5)? 
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21. Abstract 
I have developed two reverse transcription Polymerase Chain Reaction (RT-
PCR) techniques to detect and quantify the transmission stages (gametocytes) of 
Plasmodium chabaudi malaria parasites. Both the qualitative and quantitative 
techniques are based on the amplification of mRNA coding for the P. chabaudi protein 
Pcs230, which is expressed exclusively in gametocytes. The quantitative RT-PCR 
technique (qRT-PCR) was developed and validated by examining serial dilutions of 
known gametocyte densities. The method generated a high correlation between 
calibration curves of blind samples (R2 = 0.86). The technique was found to be specific, 
reproducible, and time efficient for quantification of both patent and sub-patent 
gametocytemia, with a sensitivity level 100 - 1000 times greater than microscopy. The 
qualitative RT-PCR (RT-PCR) technique was used to monitor the persistence and 
dynamics of P. chabaudi gametocytes following acute infection. Mice in two 
independent experiments were sampled daily for up to 87 days post infection. RT-PCR 
showed that gametocytes can persist for up to 8 weeks, post infection, whereas 
microscopy could only detect gametocytes up to 6 weeks. Potential applications of the 
above techniques for studying the ecology, evolution, and epidemiology of malaria 
transmission are discussed. 
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2.2. Introduction 
Molecular methods are now becoming widely utilized to study malaria parasites 
both in field and laboratory settings. The power of these techniques is increasingly clear, 
particularly for studying the ecology and evolution of parasites. In nature, malaria 
infections often occur at sub-patent levels where parasites cannot be detected by 
microscopy. This is very common in areas such as eastern Sudan, where the 
transmission of Plasmodiumfalciparum is highly seasonal and chronic sub-patent 
infections are prevalent in the dry season (Babiker and Walliker 1997; Abdel-Wahab a 
at. 2002; Hamad et at. 2002). 
Numerous studies have been conducted to examine the diversity and dynamics of 
asexual forms of malaria parasites, but the ecology of gametocytes is still poorly 
understood. Recently, reverse transcription PCR (RT-PCR) techniques have been used 
to detect RNA of proteins that are expressed exclusively in gametocyte stages, 
distinguishing gametocytes from asexual stages of P. falciparum, even at sub-patent 
levels (Babiker et at. 1999a; Menegon et at. 2000; Niederwieser et at. 2000; Schneider 
et at. 2004). Some gametocyte-specific protein genes are polymorphic, allowing the 
technique to be extended to distinguish gametocytes of different genotypes within a 
single infection (Abdel-Wahab et at. 2002). RT-PCR has shown that P. falciparum is 
capable of producing gametocytes, even when it exists as an asymptomatic, sub-patent 
infection, demonstrating the potential of such infections to sustain the cyclical malaria 
epidemics in areas of seasonal transmission (Babiker et at. 1999a). A shortcoming of 
the existing RT-PCR protocol is that it cannot quantify gametocytes (Babiker et at. 
1999a; Babiker a at. 2000; Menegon et at. 2000; Abdel-Wahab et at. 2002). Such 
quantification is important in order to gain a better understanding of the transmissibility 
of individual parasite clones that exist in mixed clone infections and the ecological 
factors that influence them. 
Recently, real-time quantitative PCR (qPCR) has been developed and 
successfully utilized to study the dynamics of different malaria species and genetically 
distinct clones in mixed infections (Cheesman et at. 2003; De Monbrison a at. 2003; De 
Roode et al. 2004b). This method enables accurate quantification of genomic DNA of 
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specific malaria parasite clones within multiple infections, but cannot selectively 
quantify different life—stages. However, quantitative reverse transcription PCR 
techniques (qRT-PCR) have also been developed and utilized for the quantification of 
RNA coding for various genes, including those of malaria parasites (Bruna-Romero et al. 
2001; Nirmalan et al. 2002). The technique has been utilized for the quantification of 
liver stages of human malaria species and a related but different method (QT-NASBA) 
has been used to examine dynamics of Plasmodiumfalciparum gametocytes (Witney et 
al. 2001; Perandin et al. 2004; Schneider et al. 2004). 
I report here on the utilization of PCR and RT-PCR protocols to detect 
parasites and monitor the longevity of P. chabaudi infections and their gametocyte 
production over time. Additionally, I developed RT-PCR and qPCR methods into a 
protocol for qRT-PCR that can specifically quantify gametocytes of the rodent malaria 
parasite P. chabaudi. 
2.3. Materials and Methods 
2.3.1. P. chabaudi infections 
Two independent experiments were carried out to monitor the longevity of 
gametocyte production of the P. chabaudi rodent malaria parasite clone CR, that is 
known to have moderate virulence in mice (Taylor et al. 1998). Infections were 
established by inoculating 5 (experiment I) and 10 (experiment II) C57B116J 5- to 8-
week-old inbred female mice (Harlan Scientific, UK) with 106  P. chabaudi parasites, 
into the peritoneal cavity, as described elsewhere (Mackinnon and Read 1999a). Mice 
were maintained at 21°C (+1- 1 °C) and fed ad libitum SDS 41B (Harlan Scientific, UK) 
rat and maintenance diet and 0.05% PABA supplemented drinking water to enhance 
parasite growth. 
Blood samples (10 tl for DNA extraction and 20 tl for RNA extraction), thin 
blood smears, and red blood cell counts (on 2 .tl of blood) from flow cytometry (Coulter 
Electronics), were taken five days a week, for 3 weeks, starting on days 3 post infection 
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(PT). After day 22 P1, samples were taken 2-3 times a week until day 87 (experiment I) 
or day 70 (experiment II). Larger blood volumes were required for RNA extraction to 
increase sensitivity for gametocytes which are in low abundance compared to asexual 
stages. Thin blood smears were stained with a 20% Giemsa solution and examined 
under a microscope at 1000x magnification to determine parasitemia and gametocytemia. 
Parasite and gametocyte densities were calculated by multiplying parasitemia and 
gametocytemia respectively by red blood cell density, measured with flow-cytometry. 
For qRT-PCR, separate infections of the P. chabaudi clone CR were established 
in three NIH mice using methods described above. The density of gametocytes 
(gametocytemia) was determined using Giemsa stained thin blood smears, and blood 
samples were taken for RNA extraction when gametocytes were visible microscopically. 
These mice were not used for the monitoring of chronic infections via RT-PCR. 
2.3.2. DNA extraction 
For general PCR, DNA was extracted from 10 p.1 of blood taken from the tail of 
P. chabaudi infected mice and added to 200 p.1 of citrate saline (0.85% NaCl, 1.5% tn-
sodium citrate), on ice. The samples were centrifuged at 11,000 rcf for 2-3 minutes to 
pellet red blood cells and the supernatant was removed. The blood pellet was stored at - 
80°C until DNA extraction. DNA was extracted using InstaGeneTh  Matrix (BioRad) 
according to the manufacturer's protocol. 
2.3.3. RNA extraction 
Parasite RNA was extracted using two methods: 
(i) For RT-PCR, RNA was extracted from 20 p.1 of whole blood, using TRIzol 
Reagent for total RNA isolation according to the manufacturer's protocol (Invitrogen 
Life Technologies). On each day of sampling 20 p.1 of blood was taken from the tail of 
each mouse and added to 200 p.1 of citrate saline on ice. The samples were centrifuged 
at 11,000 rcf for 3 minutes at room temperature to pellet the blood and the supernatant 
was removed. A lOx volume (200 p.1) of TRIzol was added to each pellet and the 
samples were vortexed immediately and stored at -80 °C until RNA extraction. RNA 
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samples were subjected to DNase treatment to remove co-extracted DNA in a 10 jil 
reaction containing 5 .tl RNA extract, 5mM Tris pH 7.6, 33mM M902, 0.27 U RNasin 
Ribonuclease Inhibitor and 4.2 U DNase I (Roche, UK), with incubation at 37 °C for 15 
minutes and 75°C for 10 minutes. 
(ii) For qRT-PCR, RNA was extracted using the Applied Biosystems 6100 
equipment and protocols. This method allows simultaneous processing of 96 samples 
and is more time efficient for use with the 96 well qRT-PCR format. To extract 
gametocyte RNA, 20 p.1 of blood was taken from the mouse tail and added to 200 p1 of 
citrate saline pre-warmed to 37 °C to avoid alterations in expression of RNA believed to 
occur at temperature changes (Fang and McCutchan 2002). Samples were centrifuged at 
11,000 rcf for 3 minutes at room temperature, the supernatant was removed and 20 p.1 
Ca2 IMg2  free RNaselDNase free PBS (Gibco) and 40 p.1 of 2X Nucleic Acid 
Purification Lysis Solution© (Applied Biosystems) were added to the blood pellet. The 
samples were then stored at -80°C. For completion of the extraction protocol, the 
samples were thawed and incubated at room temperature for 1 hour to digest blood. 
RNA was extracted using the Applied Biosystems Isolation of Total RNA from Whole 
Blood Chemistry protocol on the ABI Prism ® 6100 Nucleic Acid PrepStation with the 
RNA Blood-DNA method (Applied Biosystems). RNA was eluted in 100 p.1 of Nucleic 
Acid Purification Elution Solution and stored at -80 °C until required for quantification. 
2.3.4. PCR and RT-PCR 
Primers for PCR and RT-PCR used for longevity experiments were developed to 
amplify the gametocyte specific P. chabaudi gene pcs230 (GenBank Accession No. 
EAA15629.1 and EAA22479.1). The pcs230 sequence was determined by the P. 
chabaudi sequencing project and can be obtained from 
ftp://ftp.sanger.ac.uk/projectsfP.chabaudi . This gene belongs to the p_s48145 super-
family that encode gametocyte-specific surface proteins in malaria parasites and is only 
expressed in mature late stage gametocytes (Williamson et al. 1993; Lobo and Kumar 
1998; Niederwieser et al. 2000; Thompson et al. 2001; Bozdech et al. 2003; Le Roch et 
al. 2003; Hall et al. 2005). 
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To increase the sensitivity of detection, two rounds of PCR were performed, 
using outer primers, Pc230-(01), 5'- AAA GAT TCA GGG CAT GGC G - 3' and 
Pc230(02), 5'-TTG CCC CAC TilT TFG AGC TAC - 3'and inner primers, Pc230(N1), 
5'- ATC TGT TAT GCC 11TA TOG GAG - 3'and Pc230(N2), 5'- CuT GAT TAA TAC 
TFA GAT ACA CCA TAT GAG - 3'. The optimal annealing temperature for each set 
of primers was determined on a ThermoHybaid PCR machine using a temperature 
gradient PCR on samples known to be positive for P. chabaudi DNA. 
To determine longevity of P. chabaudi infection, PCR was performed using 
Roche 2X PCR Master mix in 20 p.1 reactions containing 2 p.1 of genomic DNA, 0.5 U 
Taq DNA polymerase, 10 mM Tris-HC1, 50 mM KC1, 1.5 MM  MgCl2, 0.2mM dNTP's, 
and 0.5 .tM of primers Pc230(01) and Pc230(02). Samples underwent PCR on an MJ 
Research DNA Engine, PTC-200; using the following conditions: denaturation at 
94'C/180 seconds, 35 cycles of amplification [94 °C/30 seconds, 5 1 - C/30  seconds, 70°CI 
60 seconds], and a terminal extension at 70 °C/600 seconds. Positive DNA controls and 
negative controls (all reagents + 2 p1 water) were run for each reaction. The outer PCR 
products were then diluted lOx and 2 p.1 of the diluted product underwent nested PCR 
using primers Pc230 (Ni) and Pc230 (N2) in a 20 p.1 PCR reaction using PCR Master 
mix (Roche) and the PCR conditions described above. 
For the detection of longevity of gametocyte production in P. chabaudi infection, 
a nested RT-PCR reaction was carried out to detect pcs230 mRNA. RNA samples 
underwent a one-step RT-PCR reaction using the AccessQuick TM RT-PCR system 
(Promega). This protocol generates cDNA from RNA and then amplifies the cDNA 
through PCR, in a single reaction. The RT-PCR reaction was carried out in a 20 p.1 
volume on the MJ Research, DNA Engine, PTC-200, with a reaction mixture using the 
AccessQuickTm Master Mix reagents consisting of 2 p.1 of RNA, 2 U of AccessQuick TM 
reverse transcriptase (Promega), 2 U t f7 DNA polymerase, 0.2 mm dNTP's, 1.5 MM 
M902, 10 p1 AccessQuickTM Master Mix (supplied by Promega as part of kit), 0.5 p.M 
of primers Pc230 (01) and Pc230 (02), and 6 p.1 AccessQuick TM H20 (Promega). 
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The RT-PCR reaction and subsequent amplification of cDNA took place under 
the following conditions, reverse transcription at 50 °C/60 minutes, denaturation at 
94°C/3 minutes, 39 cycles of amplification [94 °C/30 seconds, 61 °C/30 seconds, 70°C/6 
seconds], and a terminal extension at 70°C/600 seconds. Simultaneously an aliquot of 2 
.tl RNA from each sample were subjected to the same PCR protocol using the primers 
and the above conditions minus reverse transcriptase, to detect any carry over genomic 
DNA that might have been co-extracted with the RNA samples. Positive RNA controls, 
positive DNA controls and negative controls (all reagents + 2 tl water) were also 
included in each run. All outer RT-PCR products were diluted 1/10 then underwent a 
second PCR reaction under the same conditions as outlined for the PCR of DNA. 
2.3.5. Detection limits of PCR and RT-PCR 
To determine the sensitivity of nested PCR and RT-PCR, samples of known 
parasite and gametocyte density determined by microscopy (parasites or gametocytes/jil 
of blood) of P. chabaudi were serially diluted. Eight independent samples of extracted 
DNA were subjected to 10-fold serial dilutions creating a dilution series ranging over 
seven orders of magnitude from undiluted (neat) to diluted 1/10 7 (actual parasite density 
range tested: 1.72 x 10 5 - 4.3 x 10-3 parasites/tl). Since nested PCR of DNA amplifies 
genomic DNA from all stages of the parasite, counts of both ring stage parasites and 
gametocytes were used to determine parasite densities from thin blood smears. To 
establish the sensitivity of RT-PCR, eleven samples of RNA were subjected to 10 fold 
serial dilutions, creating a dilution series ranging from neat to diluted 1/107  for 7 
samples. None of samples 1-7 were positive below a dilution of 10- , so four more 
samples were diluted only to 1/106.  The overall dilution range tested for RT-PCR was 
1.3 x 10 - 1.0 x iO parasites/pl. 
2.36. TPC 
A qRT-PCR technique was performed to amplify and quantify RNA coding for 
the gametocyte specific protein Pcs230, using the Applied Biosystems TaqMan ® One-
Step RT-PCR Master Mix Reagents Kit, on the ABI Prism ® 7000 sequence detection 
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system. Two primers (Pc230RT-1, 5'- TCT AGT ACA TGC TilT GAA GAA GTA 
ATA GAA TAT AAT CCT AAT A - 3', and Pc230RT-2, 5'- TGC AAC GAC TilT 
CTA TAG CTA GTA GGT - 3') and a fluorescent labelled probe (Pc230RT-probe, 5'-
AAA AAT GGG ATC GAA ATA AAA - 3') were designed by Applied Biosystems 
Assays by DesignSM Service from the pcs230 gene sequence. As part of this service, 
Applied Biosystems optimized all primers and probe amplification and annealing 
conditions and combined them in a master mix. 
A one-step qRT-PCR assay was used to generate cDNA from RNA and the 
cDNA quantified, in a single reaction (Applied Biosystems). This method assumes that 
reverse transcription takes place at a constant rate between all samples (Nirmalan et al. 
2002). The reaction mix consisted of 8.5 p1 of extracted RNA, 1 .tl 20X Assay-by-
Design Mix containing primers and probes at a reaction concentration of 900 nM and 
250 nM respectively (supplied by Applied Biosystems), and the following components 
from the Applied Biosystems TaqMan ® One-Step RT-PCR Master Mix Reagents Kit: 10 
ti 2X AmpliTaq Gold® DNA Polymerase mix (contains AmpliTaq Gold® DNA 
polymerase, dNTP' s with dUTP and buffer components), 5 jil 40X RT enzyme mix 
(contains MultiScribe' Reverse Transcriptase and RNase Inhibitor). 
Samples were loaded onto 96 well optical reaction plates and placed in the ABI 
Prism® 7000 Sequence Detection System (Applied Biosystems), then underwent the 
following reaction conditions: reverse transcription at 48 °C for 30 minutes, denaturation 
at 95°C for 10 minutes, and 50 cycles of amplification [95°C for 15 seconds and 60 °C for 
60 seconds]. Data was visualized using the ABI Prism 7000 SDS Software (Applied 
Biosystems). Simultaneously, 8 RNA samples underwent conventional nested PCR 
reaction using primers Pc230 (01), Pc230 (02), Pc230 (Ni) and Pc230 (N2) to test for 
DNA contamination. 
2.3.7. Validation of qRT-PCR 
The qRT-PCR technique was validated by comparing threshold cycle values 
(number of cycles after which a sample crosses the threshold of positivity) generated 
from serial dilutions of samples of known gametocytemia. I expected the threshold 
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cycle to be negatively correlated with the number of gametocytes present in a sample, 
showing the same value when the numbers of gametocytes in two different samples are 
equal. Therefore, a strong correlation in best fit lines for threshold cycle versus 
gametocyte number generated from serial dilutions with known numbers of gametocytes, 
will demonstrate that gametocytes are accurately quantified. To further test the 
robustness of the method, I compared the accuracy of threshold cycle values calculated 
for two different types of serial dilutions, performing replicates of each set. 
The first set of dilution series was prepared blindly with extracted RNA from 
samples of known gametocyte counts (determined after qRT-PCR, via microscopy). 
Eleven, ten-fold serial dilutions (neat to 1/10) of extracted RNA (from 3 different mice) 
diluted in water were prepared. A second type of dilution curves were setup blindly to 
dilute actual parasites by using uninfected blood from NIH mice to dilute samples of P. 
chabaudi infected whole blood with known gametocyte counts (numbers calculated after 
qRT-PCR, via microscopy). Two, independent, ten-fold serial dilutions ranging from 
neat to 1/107 were generated in this manner and the dilution series samples were 
extracted on the ABI Prism ® 6100 Nucleic Acid PrepStation with the RNA Blood-DNA 
method (Applied Biosystems). The dilution of samples with the uninfected whole blood 
method more accurately simulates quantification of gametocytes from mice harbouring 
different levels of gametocyte density, and therefore accurately demonstrates the 
sensitivity of extraction as well as qRT-PCR. 
All 13 sets of RNA dilutions were quantified for pcs230 mRNA using the 
TaqMan® One-Step RT-PCR Master Mix Reagents Kit on the ABI Prism ® 7000 
sequence detection system (Applied Biosystems). The data from all curves was pooled 
and analysed using Minitab statistical software (version 13.1). Threshold cycle values 
were regressed against the logio of the number of gametocytes within samples using 
ANCOVA. All sets of serial dilutions were compared using a regression to estimate the 
validity of the qRT-PCR method. 
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2.4. Results 
2.4.1. Detection of P. chabaudi infection and gametocytes 
Conventional PCR of genomic DNA showed a mean minimum detection limit of 
3.68 ± 2.11 (± 1 S.E.) parasites/.il blood. With regard to gametocytes, RT-PCR was 
found to detect a mean minimum of 27.1 ± 11.7 (± 1 S.E.) gametocytesljil blood. 
However, in 5 out of 11 sets of serial dilutions of gametocytes infected blood, qualitative 
RT-PCR detected down to 1 gametocyte/.d of blood. These detection limits are similar 
to those found for the detection of P. falciparum asexual forms and gametocytes (Roper 
et al. 1996; Babiker et al. 1999a). In general the sets of dilution series that started with 
initial higher gametocytemia resulted in RT-PCR product at lower dilutions (Figure 2.1). 
In one case a neat sample did not give an RT-PCR product, likely due to pipetting error. 
Overall, significantly more blood samples were found to harbour P. chabaudi 
infection revealed by PCR (x2 = 16.9, P < 0.0001, d.f. = 1), and gametocytes detectable 
by RT-PCR (x2 = 24.4, P < 0.0001, d.f. = 1), than by microscopy. Across the 424 blood 
samples examined, 161 (38%) were gametocyte-positive by nested RT-PCR, whereas 
only 97 (23%) were gametocyte-positive by microscopy. There were 14 instances 
(3.30%) where gametocytes were detected by microscopy but not with nested RT-PCR, 
likely to be due to failed RNA extraction. PCR product from DNA was seen in 110 
(27%) out of 405 blood samples when RT-PCR for gametocyte RNA was negative. 
Because both gametocytes and asexual parasites contain DNA but only gametocytes 
contain Pc230 RNA, we believe these samples represent cases where asexual parasites 
were present but gametocytes were absent. Additionally, it has been shown that PCR of 
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Figure 2.1. Detection level of gametocytes with RT-PCR of RNA coding for the Pcs230 
gene. Each line represents a separate dilution series of independent samples. Y-axis 
shows number of gametocytes in the sample estimated by microscopy. X-axis shows the 
position of the sample in the dilution series with 0 being the neat (undiluted) sample and 
7 being the seventh dilution in the series (i.e. the neat sample diluted 1O). A dilution 
series up to 10-7 was performed on seven samples and up to lO on four samples. 
Where symbols are present positive RT-PCR was obtained. Where symbols are absent, 
RT-PCR was negative. In one case RT-PCR on the undiluted sample was negative, 
likely due to pipetting error. 
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2.4.2. Persistence of P. chabaudi asexuals and gametocytes from 
longevity experiments 
Figure 2.2A and 2.2B show P. chabaudi parasite density in chronic infections 
revealed by microscopy, nested PCR, and RT-PCR, for experiment I and experiment II 
respectively. In both experiments gametocytes were often detected using RT-PCR 
several days after they were no longer detectable by microscopy. Mice controlled initial 
parasitemia after about three weeks. Subsequently, the infections showed one or a few 
transient peaks of patent parasitemia that recrudesced between days 30-60, during which 
time gametocytes were frequently only detectable by RT-PCR. In most mice parasites 
were not detected after day 50 PT and none were detectable either by microscopy or 
molecular methods after day 60. The median time (± 1 SE) to clearance of gametocytes 
(i.e. time for 50% of mice to clear gametocytes) was 36 ±3 days derived by RT-PCR 
compared to 18 ± 2 days by microscopy (Kaplan-Meier test). 
Figure 2.2 (see over-page). P. chabaudi asexual forms and gametocytes detected by 
microscopy, PCR and RT-PCR for mice from experiment I (A) and II (B). Solid lines 
and dotted lines represent asexual stages and gametocytes density respectively, as 
determined by microscopy. Squares show qualitative PCR for respective days, filled 
squares are positive samples, empty squares are negative samples, absence of a square 
means no sample taken. Triangles represent qualitative RT-PCR samples for Pcs230 
gene on respective days, illustrated in the same manner. PCR and qualitative RT-PCR 
were more sensitive for detecting asexuals and gametocytes than microscopy as 
indicated by filled squares and triangles respectively. No RNA samples showed an RT-
PCR product when reverse transcriptase was omitted, thus excluding DNA 
contamination during RNA extraction. (Only mouse 4 - experiment I, and 1 - experiment 
II, shown in published paper). 
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2.4.3. qRT-PCR 
The qRT-PCR technique for gametocyte specific pcs230 RNA in 13 separate 
serial dilutions of gametocytes, detected approximately 1 gametocyte per reaction, 
corresponding to <1 gametocytes4il blood (Figure 2.3). As expected, the number of 
gametocytes was highly related to the threshold cycle (R2 = 0.86, F1,32 = 174, P < 
0.0001), with no significant differences in the slope of the relationship between the 13 
dilution series. Specifically there was no difference in slope between the 2 dilution 
series made from samples diluted in whole blood and 11 dilution series made from 
extracted RNA diluted in water (P> 0.05 in all cases). The common slope (± 1 S.E.) of 
the combined 13 dilution series was CT = - 3.20 (± 0.24). My results are very close to 
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Figure 2.3. Threshold cycle (determined by qRT-PCR) and gametocyte number 
(determined by microscopy) for 13 dilution series (11 from diluted extracted RNA, 2 
from dilutions of actual parasites with whole blood). The lines are the least squares 
regression line (solid) with 95% confidence intervals (dotted). There is a strong 
correlation between threshold cycle and gametocyte number (R2 = 0.86, F1,32 = 174, P < 
0.0001; slope ± 1 S.E. = - 3.20 ± 0.24). See text for further details. 
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2.5. Discussion 
RT-PCR techniques to detect RNA encoding proteins that are expressed 
exclusively in P. falciparum gametocytes have previously been developed (Babiker et 
at., 1999, Menegon et al., 2000). Here I have extended this protocol and established 
robust and sensitive RT-PCR and qRT-PCR methods to monitor the persistence of P. 
chabaudi gametocytes throughout infection. The techniques are based on the 
amplification of pcs230 mRNA, which is expressed exclusively in gametocytes 
(Niederwieser et al. 2000; Thompson et al. 2001; Hall et al. 2005). 
I found that the qRT-PCR detection limit ranged from between 1 to 10 
gametocytes/.l of blood making it 100 - 1000 times more sensitive than microscopy, 
with similar sensitivity levels to those found using QT-NASBA for P. falciparum 
gametocytes (Schneider et at. 2004). This very low limit of detection was reproducible 
in eleven independent sets of serial dilutions of gametocytes. Such very low 
gametocytemia would require an experienced microscopist to examine more than 1000 
fields of a well-stained thick blood smear, which could take at least 50 minutes (Babiker 
et al. 1999a). Additionally, quantification by microscopy is often inaccurate when 
gametocytes persist at the low levels (<0.01 gametocytes/ red blood cell) common in 
natural malaria infections (L. Crooks, Transmission Investment in Malaria, Ph.D. Thesis, 
University of Edinburgh, 2004)(Taylor and Read 1997). Thus, comparatively, the qRT-
PCR technique for gametocytes presented here provides a specific and highly sensitive 
estimate to gametocyte density, especially at low levels of gametocytemia. It is 
theoretically possible that different stages of gametocytes may express varying levels of 
Pcs230 RNA. However, even when using blood samples from mice on different days 
post inoculation, our results showed a strong correlation between expected and observed 
gametocyte values, showing that expression level is not a source of a large degree of 
error. 
Overall, my protocol is time efficient and capable of processing 96 samples in 8 
hours. It therefore has great epidemiological potential, and can easily be adapted to 
study human malaria parasites. This method differs from current quantification 
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protocols in that it is to my knowledge the first to quantify P. chabaudi gametocytes. 
Since this technology only requires the design of probes and primers and does not 
require the use of gene constructs as internal standards, assays can rapidly and cheaply 
be developed. In addition, by utilizing polymorphic gametocyte specific protein genes, 
the presented method can easily be adapted for tracking an individual gametocyte 
genotype when the infection is composed of multiple genotypes. Through the 
application of newly described sex specific gametocyte protein genes (Khan et al. 2005), 
the method can also be developed for the individual quantification of male or female 
gametocytes. 
I used the developed RT-PCR technique to monitor longevity of gametocyte 
production of two P. chabaudi clones. My results demonstrated that P. chabaudi 
persisted at sub-patent levels, and continued to produce gametocytes for several weeks 
as chronic infections. This result agrees with that seen in natural P. chabaudi infections 
in the natural host Thomnomys rutilans, where chronic infections lasting up to 2 years 
are often observed (Landau et al. 1999). In the present study P. chabaudi infection 
persisted for up to 60 days post-infection, however, the duration of our study was 
limited to 87 days, and therefore it is possible that additional parasite recrudescence 
phases may have been missed. In addition all infections were composed of a single P. 
chabaudi clone, whereas, in a recent study of P. chabaudi, infections consisting of 3 
clones were found to persist longer than did single-clone infections (De Roode et at. 
2003). 
The techniques presented here allow a range of hypotheses to be tested. For 
instance, chronic persistence of malaria infections in the face of sustained immune attack 
is probably due to antigenic variation by parasites (Phillips et al. 1997). Antigenic 
variation is often viewed as an adaptation to enhance transmission (Antia et al. 1996). 
Techniques such as that presented here make it possible to determine when transmission 
stages are present in chronic infections and hence the extent to which antigenic variation 
can actually contribute to parasite fitness. Of greater practical significance to malaria 
epidemiology are the findings that chemotherapy led to increased rates of 
gametocytogenesis in acute infections of P. chabaudi and increased gametocyte density 
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in infections of P.falciparum (Buckling et al. 1997; Buckling et al. 1999b; Buckling et 
al. 1999c); if the same occurs in chronic asymptomatic infections, inappropriate drug 
use could enhance malarial transmission. Moreover, multi-clone infections are the rule 
rather than the exception in malaria (Babiker and Walliker 1997; Awadalla et al. 2001). 
The dynamics of individual clones in mixed infections are complex (Bruce et al. 
2000; Read and Taylor 2001; De Roode et al. 2005b) and the transmission consequences 
of these dynamics very poorly understood. I am further developing allele-specific 
gametocyte qRT-PCR, which will make it possible to track gametocyte densities of 
individual clones in multiple-clone infections (Chapter 4). Such studies will shed more 
light on the dynamics of malaria parasites and assess biological and environmental 
factors that influence their gametocytogenesis in nature (Price et al. 1999; Bousema et al. 
2004). Gametocyte-specific quantification thus makes it possible to conduct detailed 
studies of malaria transmission biology and should help to improve predictions of 
malaria parasite responses to control measures. 
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31. Abstract 
In many malaria endemic regions individuals develop long lasting chronic 
infections characterized by extremely low parasite densities. These chronic infections 
are believed to be the source of seasonal malaria epidemics. However, the degree in 
which low density infections transmit to vectors remains unclear. In this study I 
concurrently examined the infectivity of acute and chronic stage infections of the rodent 
malaria Plasmodium chabaudi, through mosquito blood feeds. I found that acute stage 
infections transmitted to a higher proportion of mosquitoes than chronic stage infections. 
Despite extremely low parasite densities, chronic infections were still able to transmit to 
mosquito vectors. Additionally, although acute infections had higher gametocyte and 
parasite densities, transmission investment and gametocyte infectivity was greater in the 
chronic stage. My results confirm findings from the field that suggest low level chronic 
infections are likely an important reservoir for malaria transmission, especially when 
considering their long duration and potentially high lifetime exposure to vectors. 
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3.2. Introduction 
Unravelling the epidemiology of malaria transmission is critical for successful 
control strategies. In particular, understanding which cohorts of the population are 
contributing the most to transmission will help to focus currently overstretched disease 
prevention efforts. It is largely believed that the bulk of malaria transmission results 
from high parasitemia acute infections commonly occurring in young children (Githeko 
et al. 1992; Kolk et al. 2003). However, in many malaria endemic regions, individuals 
commonly develop long lasting chronic infections, which are shaped by parasite 
antigenic variation, host immunity, and seasonal variation in vector prevalence (Su et al. 
1995; Antia et al. 1996; Bottius et at. 1996; Druilhe and Perignon 1997; Babiker 1998; 
Babiker et at. 1998; Roper et al. 1998; Snounou et at. 2000; Abdel-Wahab et al. 2002; 
Hamad et at. 2002; Nassir et al. 2005). Since chronic infections can last up to several 
years, they may contribute heavily to disease persistence (Drakeley et at. 2000). 
Recent data shows that chronic malaria infections are often characterized by 
extremely low parasite densities which can only be detected through molecular methods 
(Bottius et al. 1996; Roper et al. 1996; Babiker et al. 1999a; Schneider et al. 2006). It is 
theoretically feasible that these parasite densities are so low they are non-infectious to 
vectors, particularly when further suppressed by transmission blocking immunity, and 
indeed some studies support this (Jeffery and Eyles 1955; Mulder et at. 1994; Buckling 
and Read 2001). Alternatively, there is evidence from field data that low level chronic 
infections may be responsible for triggering seasonal epidemics (Abdel-Wahab et al. 
2002; Paul et al. 2004a; Nassir et al. 2005). Additionally, a recent field study of random 
mosquito feeds after drug treatment, found that a higher proportion of individuals were 
infectious than those with detectable parasites, even by sensitive molecular methods 
(Bousema et at. 2006). If chronic infections are contributing significantly to the 
transmission reservoir, then their clearance is essential for control of the parasite. 
However, if low level parasitemia contributes insignificantly to transmission, treatment 
comes at an unnecessary financial and resistance evolution cost, particularly when 
considering that most chronic infections are asymptomatic (Hamad et al. 2000). 
To directly test the importance of chronic infections for malaria transmission, it 
is ideal to carry out simultaneous mosquito feeds on individuals maintaining low density 
chronic and high density acute stage infections, to control for temporal variation in 
mosquito susceptibility. This type of controlled experiment proves very difficult in a 
field setting due to chronic and acute infections typically appearing at different times of 
the year. Therefore, I experimentally investigated the level of transmission from each 
infection stage, utilizing the laboratory rodent malaria system Plasmodium chabaudi. 
Like many malaria parasites, including those which infect humans, P. chabaudi 
infections are comprised of both acute and chronic phases (Garnham 1954). The acute 
phase occurs over the first fortnight of infection and is characterized by a high 
parasitemia peak which is rapidly controlled by the host. Following the acute phase, 
infections enter the chronic phase, composed of small recrudescent waves in parasitemia, 
in which transmission stage gametocytes are intermittently produced (Landau et al. 1999; 
Wargo et al. 2006). Similar to human P. falciparum infections, during this chronic 
phase individuals are frequently misdiagnosed as uninfected because parasites persist at 
very low levels or are sequestered as latent forms in organs, sometimes rendering them 
undetectable even by highly sensitive molecular methods (Bousema et al. 2006; Wargo 
et al. 2006). 
I performed concurrent mosquito blood feeds on mice harbouring either acute or 
chronic stage infections, and then assessed the proportion of mosquitoes infected and 
mean oocyst burden per infected mosquito, as an indicator of infectivity. I also 
determined the number of total parasites and gametocytes on the day of the vector feed 
through qPCR and qRT-PCR, respectively. This enabled me to investigate the 
transmission investment of parasites in acute and chronic stage infections. I found that 
acute stage infections had higher asexual densities, gametocyte densities, and 
transmission to mosquitoes than chronic infections. Despite infecting very few 
mosquitoes, transmission investment and per gametocyte infectivity was greater in the 
chronic stage. My results confirm findings from the field that chronic infections are 
potentially an important malaria reservoir and may have high lifetime transmission due 
to their long persistence. 
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3.3. Methods 
3.3.1. Parasite, host and vector 
In this study I used the rodent malaria parasite Plasmodium chabaudi clone CR 
originally isolated from thicket rats, Thamnomys rutilans (Beale et al. 1978). This P. 
chabaudi clone was chosen due to its maintenance of long term chronic infections in 
laboratory mice and generally high infectivity to mosquitoes (Taylor et al. 1997a; 
Ferguson et al. 2003; Wargo et al. 2006). Hosts were 6-8 week old female C57b1J6J 
mice which were fed on 41B maintenance diet (Harlan, U.K.) and 0.05% para-amino 
benzoic acid supplemented drinking water to enhance parasite growth (Jacobs 1964). 
Vectors were the mosquito species Anopheles stephensi, maintained at 25-28 °C, 70-80% 
humidity and fed on 10% glucose in water, supplemented with 0.05% PABA as 
described elsewhere (Ferguson et al. 2003). 
3.3.2. Assessment of in-host and transmission dynamics 
To compare in-host and transmission dynamics of acute and chronic phase 
infections, I performed mosquito feeds on 21 mice harbouring infections between 5-8 
days post inoculation, and 21 mice between 27-44 days post inoculation, which had 
previously been infected with 106  clone CR parasites, as described elsewhere 
(Mackinnon and Read 1999a). These infection periods correspond to the acute (0 - 14 
days P.1.) and chronic stage (21+ days P.!.) of P. chabaudi infections, in which parasites 
are regularly detected (Wargo et al. 2006). Mosquito feeds were performed on 
individual mice on 4-8 anesthetised mice per day, with roughly equal numbers of 
chronic and acute phase mice used each day (Figure 3.1). Between 30-65 adult female 
mosquitoes, 2-8 days past emergence, were fed per mouse for 30 minutes and I 
subsequently removed all mosquitoes that did not take a blood meal. 
On the day of mosquito feeds, thin blood smears and qRT-PCR for the 
gametocyte specific gene pcs230 (Wargo et al. 2006), were used to ensure the presence 
of gametocytes before the feed occurred. To determine parasite and gametocyte density 
at the time of transmission, 20 .tl and 5 l.tl of mouse blood were taken immediately after 
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the blood feed. I do not believe that mosquito feeding altered asexual parasite or 
gametocyte numbers (Shutler et al. 2005). For quantification of gametocytes, parasite 
RNA was extracted from 20 .t1 blood and subject to qRT-PCR of the gametocyte 
specific gene PC302249.00.0 (forward primer: 5'- GCC CGA ATC ATT ATG TTF 
TAC TAT AAT GG; reverse primer: 5'- AGA TAA AAT TGC ATA TAT TCC TAA 
AGT ACT ATC TAC; TaqMan probe: 5'- FAM - CAA AGT AGA CAA TGC ACC 
AAT - MGB) as described previously (Chapter 2). For quantification of total parasites, 
DNA was extracted from 5 .tl of blood and subjected to qPCR (forward primer: 5'-
GAA GAT GCA CGT GTG GAA AAT CA; reverse primer: 5'- GAA TAG TFA TAC 
CTT TTC CCA TAA CT, TaqMan probe: 5'- FAM - CAT TTA CCT GAA GGT ATT 
CTA - MGB) as described elsewhere (Bell et al. In Press). 
To assess transmission success to vectors, mosquito midguts were dissected 9 or 
10 days after the blood feed, once oocysts had formed but before their rupture and the 
release of sporozoites (Killick-Kendrick et al. 1978). The number of oocysts were 
counted at 100x magnification to determine the proportion of mosquitoes infected and 
the average number of oocysts per infected mosquito. Dissection day had no effect on 
oocyst detection. 
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Figure 3.1. Schematic timeline of day post infection in which mosquito feeds occurred. 
All mice harbouring chronic infections (solid line) were inoculated on the same day, 
whereas, inoculation of mice harbouring acute infections (dotted lines) was staggered. 
The day inoculation occurred is represented by the left edge of each line. Mosquito 
feeds were performed on batches of mice from each infection stage on different days, as 
shown by circles above respective sampling group. Both infectious (filled circle) and 
non-infectious (open circle) mice are shown. Thirteen mice (chronic = 11, acute = 2) 
were later found by qRT-PCR to have no gametocytes (circles with grey stripes) and 
were dropped from all analysis, as none of these were infectious to mosquitoes. 
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3.3.3. Statistical analysis 
To determine infectivity, the proportion of mosquitoes infected and the number 
of mice which were infectious in acute versus chronic infections were compared using 
Mann-Whitney U and chi-square tests, respectively. When comparing gametocyte 
production in relation to asexual parasites, general linear model analysis was conducted, 
with infection type as the explanatory variable (acute verses chronic). Parasite densities 
were log transformed and proportions arcsin-square-root transformed, to meet the 
assumptions of normality and homogeneity of variance. For the assessment of 
transmission as a function of gametocyte density, I only utilized positive infections to 
avoid confounding the analysis with zeros and false negatives, this did not change the 
observed trends. Since variances were unequal between the two infection stages in this 
analysis, non-parametric Mann-Whitney U-tests and Spearman's rank correlations were 
implemented. All statistical tests were carried out in Minitab version 13. 
3.4. Results 
Thirteen mice (chronic = 11, acute = 2) were found to have zero gametocytes at 
the time of the blood feed by qRT-PCR (Figure 3.1). This was likely due to host 
clearance. None of these mice were infectious to mosquitoes and therefore they were 
dropped from all analyses. Below I refer to the 29 mice remaining with detectable 
gametocytes. In two mice, parasites were not detectable by qPCR, but gametocytes 
were detectable by qRT-PCR. This is not surprising considering qRT-PCR is one to two 
orders of magnitude more sensitive than qPCR. These parasite density values were 
estimated to be just below the detection level of qPCR (10004t1 blood). Since typically 
less than 1% of qPCR counts reflect gametocyte densities, for clarity below I refer to 
counts derived from qPCR as asexual densities and counts from qRT-PCR as 
gametocytes. 
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3.4.1. Dynamics from all mice harbouring acute or chronic infections 
In general, transmission success was very low, resulting in only 13% (152/1167) 
of mosquitoes becoming infected. The mean proportion of infected mosquitoes was 
much greater from blood feeds on acute versus chronic stage infections (Figure 3.2, 
Man-Whitney U-test: W = 95, P = 0.033, N = 19, 9). However, there was no significant 
difference in the number of mice that were infectious to mosquitoes between the two 
infection stages (Figure 3.2, chronic: 3/10, acute: 11/19;x 2 = 2.04, P= 0.15, d.f. = 1). 
On the day of mosquito blood feeds, higher asexual and gametocyte densities 
were observed in acute compared to chronic infections (Figure 3.3A; asexuals: F1 ,27 = 68, 
P < 0.001; gametocytes: F1,27 = 11, P = 0.003). There was a strong linear positive 
relationship between asexual and gametocyte density (Figure 33B, F1 ,26 = 35, P < 0.001, 
R2 = 0.7) which had a larger intercept in chronic compared to acute infections (infection 
type main effect: F1,26 = 5.5, P = 0.03; interaction with covariate: F1,25 = 0.38, P = 
0.543). Thus, for a given asexual parasite density, gametocyte densities were greater in 
the chronic compared to acute stage. The percentage of parasites that were gametocytes 
was also higher in the chronic stage (Figure 3.3C, F1 ,27 = 10, P = 0.004), suggesting that 
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lFiiguinre 3.2. Infectivity of acute (grey bars) versus chronic (patterned bars) infection 
stages. The percentage of mice which transmitted (with 95% binomial confidence 
interval) to at least one mosquito (left), and the mean percentage of mosquitoes infected 
(± 1 S.E.M) of those which took a blood meal (right), are given. Infectivity was 
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Figure 3.3. The relationship between asexual and gametocyte density in chronic and 
acute stage infections. (A) Log transformed mean (± 1 S.E.M) asexual (black line) and 
gametocyte (grey lines) densities were lower in chronic compared to acute infections. 
(B) There was a strong linear correlation between gametocyte and asexual density, the 
intercept of which was higher in chronic (grey line) compared to acute (black line) 
infections. Regression data is shown on log scale and best fit lines are given. (C) The 
mean percentage of total parasites that were gametocytes (± 1 S.E.M) also revealed 
higher gametocyte investment in chronic infections. 
3.4.2. Dynamics from müce hftcUous o iecotrs 
When examining just those mice which transmitted to mosquitoes, there was a 
slightly higher number of oocysts per infected mosquito (Figure 3.4A), and proportion 
of mosquitoes infected (Figure 3.5A), from blood feeds on acute versus chronic 
infections, although this difference was only significant for the proportion of mosquitoes 
infected (Man-Whitney U-test; oocysts/mosquito: W = 90, P = 0. 14, N = 11, 3; 
proportion infected: W= 97, P = 0.015, N = 11, 3). There was a weak trend of greater 
numbers of oocysts (Figure 3.4B) and infected mosquitoes (Figure 3.5B) with increasing 
gametocyte density (Spearman's rank; oocysts, Rs = 0.42, P = 0.13; infected mosquitoes, 
Rs = 0.76, P = 0.002; N: acute =11, chronic = 3). Closer investigation of this 
relationship as a ratio, revealed that more oocysts (Figure 3.4C) and infected mosquitoes 
(Figure 3.5C) were observed for a given gametocyte density in chronic versus acute 
infections (oocysts: W= 66, P = 0.006, N = 11, 3; mosquitoes infected: W= 71, P = 0.04, 
N = 11, 3). Therefore, although acute infections were generally more infectious than 
chronic infections, there was some evidence that per gametocyte infectivity was slightly 
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Figure 3.4. Number of oocysts in those mosquitoes which became infected. (A) The 
mean number of oocysts per infected mosquito (± 1 S.E.M) was not significantly greater 
in acute compared to chronic infections. (B) There was a weak trend of increasing 
numbers of oocysts per mosquito with higher gametocyte densities (Spearman' s rank) on 
the day of the blood feed (both log transformed). (C) The ratio of mean oocyst number 
to mean gametocyte density (± 1 S.E.M) revealed that a given gametocyte density 
resulted in greater numbers of oocysts per mosquito, in chronic compared to acute 
infections (Mann-Whitney U-test). Only the 14 mice which were infectious to 







• 	' 	0.8 
0.6 o V 
V 	0.4 00 
CO V 





0 0. 000.0 
0 	2 	4 	 Acute 


















Figure 3.5. Percentage of infected mosquitoes from those mice which were infectious. 
(A) The mean percentage of infected mosquitoes (± 1 S.E.M) was greater in acute 
compared to chronic infections. (B) There was a general trend of increasing number of 
infected mosquitoes with higher gametocyte densities (Spearman's rank). (C) The ratio 
of mean percentage of infected mosquitoes to mean gametocyte density (± 1 S.E.M) 
revealed that a given gametocyte density infected greater numbers of mosquitoes in 
chronic compared to acute infections (Mann-Whitney U-test). Only the 14 mice which 
were infectious to mosquitoes were included in these analyses (acute =11, chronic = 3). 
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3.5. Discussion 
Long duration, low parasitemia chronic infections which are common in many 
malaria endemic regions, could potentially be an important transmission reservoir 
(Babiker et al. 1998; Hamad et al. 2000; Abdel-Wahab et al. 2002; Nassir et al. 2005; 
Schneider et al. 2006). However, there is little direct information on whether 
transmission from such low parasitemia infections occurs and if so, to what degree this 
transmission will influence the epidemiology of the parasite (Jeffery and Eyles 1955; 
Paul et al. 2004a; Bousema et al. 2006). It is theoretically possible that mosquito 
vectors rarely become infected when taking a blood meal from individuals with parasite 
densities below a certain threshold. 
Here, I conducted concurrent mosquito blood feeds on laboratory mice with 
acute or chronic stage infections of the rodent malaria P. chabaudi and examined direct 
transmission. I found that parasites in the acute stage infected more mosquitoes than 
those in the chronic stage. A very limited amount of transmission from chronic stage 
infections did occur, despite extremely low parasite and gametocyte densities. 
Additionally, although both gametocyte and parasite densities were higher in acute 
infections, chronic infections appeared to have greater transmission investment, in that a 
larger proportion of the circulating parasites were gametocytes. Gametocyte infectivity 
was also higher in chronic infections, demonstrated by a larger number of oocysts and 
infected mosquitoes for a given gametocyte density. The combined increased 
transmission investment and gametocyte infectivity could explain why despite lower 
gametocyte numbers in chronic infections, there was no significant difference in the 
proportion of mice which were infectious or the average oocyst number per infected 
mosquito, when comparing the two infection stages. In this case I cannot, however, rule 
out the possibility that no differences were observed due to low statistical power. 
The mechanisms behind the observed increased gametocyte production and 
infectivity in chronic infections in this study are unknown. Both could feasibly be 
controlled by phenotypic plasticity in the parasite. It is well documented that malaria 
parasites can increase gametocytogenesis in response to environmental cues such as 
anemia and drug treatment (Gautret et al. 1996b; Buckling et al. 1999c; Nacher et al. 
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2002; Reece et al. 2005; Ali et al. 2006). Additionally, alterations in male to female 
gametocyte sex ratio to optimize fertility, and therefore vector transmission, have also 
been observed (Paul et al. 2000; West et al. 2002; Gardner et al. 2003; Reece et al. 
2005). Similar parasite responses to cues such as infection duration, parasite density, 
immunity, or anemia, could conceivably be in operation in chronic infections. 
It is also possible that gametocyte infectivity is influenced indirectly by host 
condition. Since parasite densities are higher in acute infections I would expect greater 
levels of red blood cell death and therefore anemia and immunity. Both of these factors 
have generally been linked to poor quality blood meals and low transmission to vectors 
(Carter et al. 1979; Gautret et al. 1996b; Paul et al. 2000; Paul and Brey 2003). To 
counteract these effects, increased gametocytogenesis, sex ratio alteration, and 
gametocyte infectivity, through the stimulation of erythropoietin (Epo), is believed to 
occur. However, I assessed acute infections very soon after parasite inoculation (day 5-
8), just when anemia begins to take place and before Epo typically elicits a response 
(Gautret et al. 1996a; Gautret et al. 1996b; Reece et al. 2005). Even if increased 
transmission investment was occurring in acute infections, the response was clearly 
smaller than that elicited in chronic infections. 
My findings strongly suggest that P. chabaudi has evolved strategies for 
adjusting resource allocation in chronic infections to optimize transmission in the face of 
extremely low parasite densities. The epidemiological impact of this appears to be very 
small due to the low proportion of mosquitoes becoming infected from mice in the 
chronic stage. However, it is important to note that transmission in this study was 
generally very poor. The reasons for this are unclear but may be partly influenced by A. 
stephensi not being the natural vector of P. chabaudi. Unfortunately, the natural vector 
of P. chabaudi is unknown. However, previous studies of A. stephensi as a vector for P. 
chabaudi have generally observed much higher transmission success (Mackinnon and 
Read 1999a). Why transmission was particularly low in my study is unclear, however, I 
assume that the confounding effects of reduced transmission influenced both infection 
stages equally, or if anything, underestimated the transmission potential of chronic 
infections. 
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A plausible explanation for why infectivity in chronic infections was so low in 
this study is the possibility of an upper limit to gametocyte investment and transmission 
which P. chabaudi can maintain. If parasite densities are constricted in chronic 
infections by the host immune response, and a certain threshold of asexual parasites 
must be maintained to continue persistence in the host, gametocyte density would be 
restricted to very low levels (Druilhe and Perignon 1997; Taylor and Read 1997). This 
might explain why even when at their highest per parasite densities in chronic infections, 
gametocytes still only made up 1% of the total parasites circulating in the host. A 
strategy around this could be for the parasite to elevate gametocyte production or 
aggregate when mosquito vectors are present and transmission is guaranteed (Gaillard et 
al. 2003; Paul et al. 2004a). One study with P. chabaudi did reveal increased 
gametocytogenesis in response to mosquito probing (Billingsley et al. 2005), but a more 
recent study observed no such response (Shutler et al. 2005), in neither case were 
chronic infections assessed. 
It is also important to consider the role of transmission blocking immunity in 
shaping the epidemiological relevance of chronic versus acute infections. Studies vary 
on whether transmission blocking immunity waxes or wanes as the duration of the 
infection increases (Ranawaka et al. 1988; Fleck S. L. et al. 1994; Mulder et al. 1994; 
Taylor and Read 1997). Transmission blocking immunity is hypothesized to be stronger 
when gametocyte densities are higher (Naotunne et al. 1991; Boudin et al. 2004; 
Drakeley et al. 2006), but the proportion of parasites which are gametocytes in the blood 
stream may play an equally important role. I observed gametocyte infectivity was 
lowest during the acute phase where gametocyte densities were highest, and increased in 
chronic infections where gametocyte densities were lowest. Therefore, my results 
suggest that transmission blocking immunity is greater at the start of infection, and the 
effect wanes when densities drop below a certain threshold. This agrees with the results 
of Drakeley et al. (2006), who found higher transmission blocking immunity and 
gametocytemia in children, compared to adults. 
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In conclusion, these results suggest that, although acute infections are likely to 
contribute to the bulk of transmission, chronic infections may play an important role in 
the spread of disease, particularly due to their long duration and therefore increased 
potential for exposure to vectors. This could be particularly critical when mosquito 
densities are very low or fluctuate dramatically between widely spaced seasons. These 
findings support those from the field which suggest transmission from chronic infections 
maintains seasonal malaria epidemics (Abdel-Wahab et al. 2002; Paul et al. 2004a; 
Nassir et al. 2005). Therefore, the consideration and treatment of low level chronic 
infections may be critical for designing optimal control strategies and resource 
investment. 
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4. TRANSMISSION INVESTMENT OF MALARIA 
PARASITES IN RESPONSE TO IN-HOST COMPETITION 
4.1. Abstract 
Conspecific competition occurs in a multitude of organisms, particularly in 
parasites, where several genotypes are commonly sharing limited resources inside their 
host. This competition dynamic creates an evolutionary dilemma where genotypes face 
a trade-off between in-host replication and transmission. Theory is contradictory on 
whether increased or decreased transmission investment is the best strategy to maximize 
genotype fitness in the face of competition, and experimental evidence is limited. I 
developed and utilized a genotype-specific method of qRT-PCR to quantify Plasmodium 
chabaudi in-host replication and transmission stages in mixed-genotype infections, in 
two mouse strains. I found that in infections composed of an avirulent and virulent 
parasite genotype, competitive suppression of both genotypes occurred, with the virulent 
genotype obtaining overall competitive superiority. In response to competitive 
suppression, there was little evidence of an adaptive alteration in transmission stage 
investment, apart from a small shift of resources away from transmission towards in host 
replication by one clone, in one mouse genotype. The plasticity in commitment to 
transmission did not result in a competitive advantage, although it might have reduced 
the disadvantage. Generally, competitive suppression of blood-stage malaria parasites 
resulted in equally reduced transmission stage production. Thus, this study supports 
current literature, which predicts that conspecific within-host competition will result in a 
competitive advantage and positive selection for virulent genotypes and the evolution of 
virulence. 
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Parasites exhibit a wide array of complex life cycles, which commonly involve 
different life stages for in-host replication and between-host transmission. Protozoan 
parasites for example, often undergo clonal expansion within their host and produce 
morphologically distinct propagules for transmission to vectors. Likewise, parasitic 
worms, such as cestodes, typically grow and mature within their host and then release 
eggs into the environment. Ultimately, resources available to a parasite must be divided 
between the production of transmission stages and in-host replication, thereby creating a 
replication-transmission trade-off, analogous to the more general growth versus 
reproduction trade-off found in many organisms (Perrin and Sibly 1993; Amarasekare 
and Nisbet 2001). 
Several factors, such as environmental conditions, are likely to shape the life 
history strategies that parasites choose to maximize fitness while balancing the trade-off 
between replication and transmission (Gautret et al. 1996b; Buckling et al. 1997; 
Buckling etal. 1999b; Eisen and DeNardo 2000; Dezfuli et al. 2001; Mackinnon etal. 
2002a; Osgood et al. 2003; De Roode et al. 2004a; Paul et al. 2004b; De Roode et al. 
2005b; Vizoso and Ebert 2005; Michaud et al. 2006; Bell et al. In Press). How 
pathogens solve this fundamental life history dilemma will likely impact on medically 
and epidemiologically relevant traits (Day 2003), since disease severity is frequently a 
consequence of densities of in-host replication stages, and infectiousness a consequence 
of transmission stage densities. 
Like many protozoan parasites, malaria is subject to a replication-transmission 
trade-off (Taylor and Read 1997). For much of its life cycle a malaria parasite 
undergoes asexual stage replication in the mammalian host. During asexual replication a 
small proportion of asexual forms become committed to develop into sexual stage 
gametocytes. Gametocytes are the only life stage infectious to vectors and they cannot 
replicate within the vertebrate host, therefore, their only contribution to parasite fitness 
is through transmission. Phenotypic plasticity in gametocyte production, in response to 
environmental changes such as drug pressure and anaemia, is commonly reported and 
55 
generally demonstrates higher gametocyte numbers with deteriorating in-host conditions 
(Buckling et al. 1999b; Buckling et al. 1999c; Nacher et al. 2002; Paul et al. 2004b; Ali 
et al. 2006). 
An important environmental factor that malaria parasites face is the presence of 
genetically unrelated genotypes in the mammalian host, typically resulting in conspecific 
interactions (Babiker and Walliker 1997; Druilhe et al. 1998; Anderson et al. 2000; 
Read and Taylor 2001). There is now strong experimental and indirect epidemiological 
evidence that these interactions are often competitive, such that malaria genotypes suffer 
reduced replication in the presence of competing genotypes (Daubersies et al. 1996; 
Mercereau-Puijalon 1996; Arnot 1998; Paul et al. 2004b; De Roode et al. 2005b; Bell et 
al. In Press). 
In-host competition is believed to play a critical role in the evolution of traits 
such as virulence, which is predicted to be positively linked with competitive ability 
(Mosquera and Adler 1998; Brown et al. 2002). However, transmission has rarely been 
examined as a component of competitive performance. In malaria there appears to be a 
broad correlation between the total proportional composition of parasite genotypes in the 
mammalian host and insect vector; however, the transmission investment of individual 
genotypes was not assessed (Taylor and Read 1998; De Roode et al. 2005b). This lack 
of transmission investment data can be partly attributed to that fact that, until very 
recently, it has been impossible to quantify clone frequencies in the malaria transmission 
stage population. 
In response to competitive suppression it is plausible that genotypes will divert 
more resources into transmission to maximize fitness. An alternative strategy might be 
for parasite genotypes to shift resources away from transmission towards replication, so 
as to maximize in-host numbers and competitive success. Mechanisms to drive either of 
these responses in malaria are certainly feasible, as parasites could detect crowding in 
their environment, anaemia, or even the presence of other clones through genotype 
specific antigens (Yap and Stevenson 1994; Gautret et al. 1996b; Nacher et al. 2002; 
Paul and Brey 2003). Many theoretical studies have invoked such phenotypic plastic 
responses (Koella and Antia 1995; van Baalen and Sabelis 1995; Antia et al. 1996; West 
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et al. 2001) and they have been observed in experimental studies in some systems 
outside of malaria, typically suggesting increased transmission investment (Davies et al. 
2002; Stockley and Parker 2002; Michaud et al. 2006). 
Currently, there is not enough evidence to distinguish between increased or 
decreased transmission investment of malaria genotypes in response to conspecific 
competition. Unravelling these two theories requires a method for genotype-
distinguishing stage-specific quantifications. Here I report on the development and 
utilization of a quantitative reverse transcriptase PCR assay (qRT-PCR) for clone-
specific quantification of gametocytes, of a competing avirulent and virulent clone in 
mixed infections of the rodent malaria Plasmodium chabaudi. I estimated the 
transmission investment of each clone during conspecific competition in two mouse 
strains, using the qRT-PCR technique, as well as asexual growth and replication using a 
quantitative PCR (qPCR) assay (Bell et al. In Press). I found that each clone 
experienced competitive suppression of both asexual and transmission stage production 
in mixed infections. There was evidence that the less virulent clone shifted resources 
away from transmission investment towards in-host replication, in response to 
competition. This response only occurred in one mouse genotype and did not affect the 
overall performance of the clone, suggesting that competitive suppression of blood-stage 
malaria parasites results in reduced transmission to the insect vector. 
43. Methods 
4.3.1. Parasites and hosts 
I used two genetically distinct P. chabaudi clones AJ and AS, originally isolated 
from thicket rats, Thamnomys rutilans (Beale et al. 1978). Clone AS reaches lower 
within-host densities, has a lower competitive ability and causes lower virulence than 
clone AJ (De Roode et al. 2005b; Bell et al. In Press). Hosts were 6-8 week female 
C57b1J6J and CBA/ca inbred mice (herein referred to as C57 and CBA) fed on 41B 
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maintenance diet (Harlan, U.K.) and water supplemented with 0.05% PABA to enhance 
parasite growth (Jacobs 1964). Mice were kept on a 12:12 h light-dark cycle. 
I inoculated 14 C57 and 20 CBA mice per treatment with 106  AJ,  106  AS, or 106 
AS + 106  AJ parasites (2 x 106  total parasites) as described elsewhere (Mackinnon and 
Read 1999a). I utilized equal numbers of each parasite clone for both single and mixed 
infections in order to compare the dynamics of each clone when it is alone versus in the 
presence of a competitor. 
4.3.2. Monitoring infection dynamics 
Total parasitemia (percentage of red blood cells infected) and gametocytemia 
were monitored from day 3-17 post infection using thin blood smears of tail blood fixed 
in methanol and stained in 10% Giemsa. To determine parasite and gametocyte density, 
flow-cytometry (Coulter Electronics) counts for red blood cell density were taken. 
Clone-specific parasite density of both AS and AJ in single and mixed infections was 
monitored using qPCR on 5 tl of whole blood taken each day of sampling, as described 
elsewhere (Bell et at. In Press). Since qPCR relies on the quantification of parasite 
DNA, it cannot selectively differentiate between parasite life stages and therefore 
provides an estimate of the total number of parasites circulating in the blood. To 
accurately quantify production of transmission stages, gametocyte density was 
monitored for clones AS and AJ individually on each sampling day, except days 3 and 9, 
using qRT-PCR as previously described (Chapter 2), but with the following minor 
modifications. 
Briefly, for gametocyte qRT-PCR, 20 F.tl  of mouse tail blood was sampled and 
placed in a 90 tl 1:2 volume mix of Ca 2 fMg2 free PBS (Gibco) and 2X Nucleic Acid 
Purification Lysis Solution © (Applied Biosystems). To prevent possible alterations in 
gene expression and degradation of RNA (Fang and McCutchan 2002), all blood 
samples were immediately placed in lysis buffer, vortexed gently and stored at -80 °C. 
Total RNA was then extracted on the ABI P rism® 6100 machine as outlined elsewhere 
(Chapter 2). To generate cDNA, the extracted RNA underwent reverse transcription 
using the High-Capacity cDNA Archive Kit (Applied Biosystems) in a 50 tl reaction 
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containing 25 p1 of RNA and 25 p1 of kit reagents with the following components: 5 p1 
lox RT buffer, 2 p1 25X dNTP mixture, 5 p1 lox random primers, 2.5 p1 (5U/pl) 
MultiScribe reverse transcriptase, and 10.5 p1 RNase-free H20). The reaction was then 
incubated on an MJ Research DNA Engine, PTC-200 at 25°C for 10 minutes followed 
by 37°C for 2 hours and 4 °C hold, then stored at -80 °C. 
To complete gametocyte quantification, cDNA converted from RNA underwent 
qPCR on an ABI Prism® 7000 using genotype-differentiating forward primers for P. 
chabaudi clones AS (5'- AAG iTT ACC TGA GAG TAC AAA TAT AAT AGG TGT 
A - 3') and AJ (5'- TGA CAG TAC AAA TAT AAT AAG CGC AGT T - 3') in 
conjunction with a conserved reverse primer (5'- GCT GCT ATA CGT GTT ATA AAT 
CCT AliT ACT - 3') and TaqMan® MBG probe (5'- 6FAM - TGT TAT AAT TGT 
GilT CAC CCT ATC - 3'). The qPCR reactions were set up for each clone at a final 
volume of 25 p1 using 7 p1 of cDNA, 900 nM forward and reverse primers, 250 nM 
probe, and ix concentration (supplied at 2X) TaqMan ® Universal PCR Master Mix 
(contains AmpliTaq Gold DNA Polymerase, dNTP' s with dUTP, Passive Reference, 
Optimized Buffer) (Applied Biosystems). All reactions were run on the ABI Prism ® 
7000 sequence detection system under the following conditions: 50 °C for 2 minutes, 
95°C for 10 minutes, then 45 cycles of: 95°C for 15 seconds and 60 °C for 1 mm. All 
primer and probe concentrations were determined through optimizations of minimum CT 
values. 
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The primers and probes for gametocyte qRT-PCR quantification were designed 
to amplify the gametocyte-specific P. chabaudi gene PC 108476.00.0 (herein referred to 
as pcslO), the homolog of the Plasmodiumfalciparum gametocyte gene pfsl6, known to 
be exclusively expressed in gametocytes. Expression of pfsl6 begins in gametocyte-
committed ring stages, as one of the first events in sexual differentiation, and continues 
into late stage gametocytes and gametes (Baker et al. 1994; Bruce et al. 1994; Dechering 
et al. 1997; Dechering et al. 1999; Niederwieser et al. 2000; Schneider et al. 2004). 
Although less is known about pcsl6 in P. chabaudi, many genes, including those 
expressed in gametocytes, are highly conserved between P. falciparum and rodent 
malaria species such as P. chabaudi (Janse et al. 1994; Carlton et al. 1998; Janssen et al. 
2001; Thompson etal. 2001; Carlton etal. 2002; Waters 2002; Khan and Waters 2004; 
Hall et al. 2005). 
To verify the gametocyte specificity of pcsl6, I quantified an array of samples 
for both clones AS and AJ with varying levels of gametocytes using the pcsl6 assay and 
a separate qRT-PCR assay developed for the P. chabaudi gene PC302249.00.0, which is 
the highly conserved homologue of the Plasmodium berghei gene PB000198.00.0 (P. 
chabaudi primers: forward primer 5'- CAC AAT ATA GTA TAA AAG TAG GAC 
TFG AAA ATA ATA GTA G - 3', reverse primer 5'- GGA ATA TGG GAT AYI' GTC 
AAA GGA TAT AC -3', probe 5'- FAM - TTF TCC ACT TAC AAC TCC A -3'). In 
P. berghei this gene has been demonstrated to have specific expression in late stage 
gametocytes using GEP and promoter analysis (Khan et al. 2005). 
I found a strong correlation between the qRT-PCR counts from the pcsl6 and 
PC302249.00.0 assays for each clone across gametocyte densities spanning more than 
four orders of magnitude (AJ: R2 = 0.82, F1,43 = 131, P < 0.001, slope = 1.08 ± 0.095, 
intercept = -0.23 ± 0.28; AS: R2 = 0.6, F1,26 = 41, P < 0.001, slope = 1.14 ± 0.18, 
intercept = -0.35 ± 0.6) as well as with microscope blood smear counts across 
gametocyte densities spanning more than one order of magnitude (R2 = 0.33, F18 = 5.4, 
P = 0.049, slope = 1.56 ± 0.66, intercept = -1.8 ± 2.1). 
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These results, combined with continued accurate quantification of both AJ and 
AS clones in artificial mixtures using the pcsl6 assay (correlation observed vs. expected: 
AJ: R2 = 0.95, F151 = 896, P < 0.001, slope = 0.954 ± 0.032, intercept = 0.12 ± 0.08; AS: 
= 0.88, F1,8= 234, P < 0.0001, slope = 0.99 ± 0.064, intercept = -0.035 ± 0.15), 
further verified gametocyte specificity and accuracy of qRT-PCR. 
Standards for qRT-PCR were developed using single infections of genotypes AS 
and AJ with high levels of gametocytes and few asexual parasites. RNA was extracted 
and converted to cDNA as outlined above and a six step ten-fold dilution series of 
cDNA was set up for each quantification run. The same clone AS and AJ standards 
were utilized throughout the experiment, creating an internal control for variation in 
levels of pcsl6 RNA. 
4.3.3. Statistical analysis 
All statistical analyses were carried out using general linear models in Minitab 
version 14. Competitive performance was examined by comparing the performance of a 
clone on its own in single infections versus in the presence of a competitor in mixed 
infections, with explanatory variables mouse 'strain' (C57 or CBA), parasite 'clone' (AS 
or AJ) and infection type 'competition' (clone alone or in mixed infection). For all 
GLM analyses, maximal models were tested (variation in factor = 'clone' + 'strain' + 
'competition' + 'clone'*'strain' + 'clone'*'competition' + 'strain'*'competition' + 
'clone' * 'strain' * 'competition') and terms were dropped from the model if insignificant 
(P> 0.05) until the minimal significant model was obtained. When testing for 
correlations, terms were added as covariates in the analysis. Due to the same mice 
hosting both genotypes AS and AJ in mixed infections, I compared the performance of 
the two genotypes to each other in single infections but not in mixed infections, to avoid 
violating assumptions of independence. Where necessary, data was log (counts) or 
arcsin-square-root transformed (proportions) to meet assumption of normality and 
homogeneity of variance; likewise, gametocyte proportion data was first arcsin-square-
root and then Box-Cox transformed. 
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When examining total parasite or gametocyte production I summed densities up 
to day nine which was the latest day in which enough mice survived to compare the 
treatment groups. To analyse the proportion of AS parasites in mixed infections I 
sampled asexual density and then gametocyte density from the same mouse one day later. 
4.4. Results 
4.4.1. Disease severity 
Higher than anticipated levels of host morbidity in all infection types resulted in 
the euthanasia or death of several mice during the experiment. In infections composed 
of a single clone, 3 out of 34 (8.8%) AS-infected and 14 out of 34 (41%) AJ-infected 
mice died, whereas in mixed infections 11 of 34 (32%) mice died. Thus, as in previous 
experiments, AJ was the more virulent clone (x2 = 15.5, P = 0.008, d.f. = 5). 
Approximately equal levels of host mortality were observed in CBA (18/60 or 
30%) and C57 mice (10/42 or 24%). In most cases, mouse death occurred around peak 
parasitemia, when disease symptoms were most severe. Mouse death prevented some 
treatment groups from being tracked for the duration of the experiment; however, all 
groups were followed until at least day 9 post-infection (Figure 4.1). In spite of host 
mortality, I was still able to utilize over 2000 qPCR and qRT-PCR samples for analysis. 
4.4.2. In-host asexual and sexual densities 
Total parasite density and total gametocyte density showed similar kinetics 
during the infections, peaking around day 8 and then trailing off (Figure 4.1). 
Transmission stage production closely mirrored in-host replication for each clone, with 
the number of gametocytes an order of magnitude or two lower than total parasites on 
any given day (Figure 4.1). Since less than 10% and usually less than 1% of DNA total 
parasite qPCR counts reflect gametocyte densities, below I refer for clarity to counts 
derived from qPCR as asexual densities and counts from qRT-PCR as gametocytes. 
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In infections containing only a single clone, genotype AS produced fewer 
asexuals and gametocytes than genotype AJ (Figure 4.2, asexuals: F1 ,29 = 20, P < 0.00 1, 
gametocytes: F1,30 = 132, P < 0.001), with the difference in asexual density between the 
two parasite clones being significantly greater in C57 compared to CBA mice (parasite 
clone*host strain interaction: asexuals, F1,29 = 8, P = 0.009; gametocytes, F1,29 = 1.86, P 
= 0.183). In general more asexuals and gametocytes were produced in CBA compared 
to C57 mice (asexuals, F1,29= 46, P <0.001, gametocytes, F1,30= 78, P < 0.001). 
For both parasite clones, the presence of the other clone reduced asexual and 
gametocyte densities (Figure 4.2). Thus, each clone experienced competitive 
suppression (asexuals: AS, F1,32= 62, P <0.001; AJ, F1,28= 13, P <0.001; gametocytes: 
AS, F1,31 = 29, P < 0.001; AJ, F1,26= 7, P = 0.012). The level of suppression of 
asexuals was similar in both host strains (competition *host strain interaction: AS, F1131 = 
0.23, P = 0.635; AJ, F1,26= 0.83, P = 0.370). However, competitive suppression of 
gametocytes was greater in CBA compared to C57 mice for clone AS (competition*  host 
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Figure 4.1. Asexual and gametocyte densities during the course of infection for parasite 
clones AS (A, C) and AJ (C, D) in mouse strains C57 (A, B) and CBA (C, D). Clone 
performance is shown in single-clone infections (solid lines) or in the presence of the 
other clone (dotted lines). Gametocyte densities were determined by clone-specific 
qRT-PCR (grey lines) and asexual densities by clone-specific qPCR (black lines). 
Plotted points are mean (± 1 S.E.M) of up to 12 mice; lines end when no mice were alive 































Figure 4.2. Total number of asexual parasites (A) and gametocytes (B) up to day 9 post 
infection. Plotted points are least squares means (± 1 S.E.M) for clone AJ (black lines) 
or AS (grey lines) in mixed (dotted lines) or single infections (solid lines), for each 
mouse strain. Only the 65 mice surviving up to day 9 post-infection were used to 
determine the mean for each treatment group (CBA mice: AS alone = 12, AS mixed = 
10, AJ alone =7, AJ mixed =10; C57 mice: AS alone = 7, AS mixed = 6, AJ alone = 7, 
Ai mixed = 6). In all cases there was competitive suppression of parasites. 
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4.4.3. Transmission investment in relation to total parasite 
production 
For both clones, there was a significant positive relationship between the total 
number of asexual parasites present during an infection and the total number of 
gametocytes (Figure 43A and B; AS: R2 = 0.86, F1 ,30 = 17, P < 0.001; AJ: R'= 0.74, 
F1,26 = 42, P < 0.001; all higher order interactions with the covariate were non-
significant). Overall, more gametocytes were produced per asexual parasite in CBA 
compared to C57 mice (Figure 4.3; AS, F1 , 30 = 8, P = 0.007; AJ, F1,26= 21, P < 0.001). I 
found no effect of competition on the relationship between total gametocyte and asexual 
parasite density for clone AJ (Figure 4.3B, competition: F1 , 21 = 0.34, P = 0.57; 
competition*asexual density: F1,21 = 0.01, P = 0.92), or for clone AS in C57 mice 
(Figure 43A). However, in CBA mice, clone AS (Figure 43A) produced fewer 
gametocytes for a given asexual parasite density when in competition as compared to on 
its own (mouse strain* competition interaction: F1,30= 7, P < 0.013). 
An alternative way of looking at transmission investment is to examine the 
proportion of parasites in an infection that were gametocytes (Figure 4.3C, D). An 
average of 3% of parasites produced by clone AJ were gametocytes and 0.3% produced 
by clone AS (Figure 43C, D), with the proportional gametocyte production being higher 
in CBA than C57 mice (mouse strain main effects: AS, F1,31 = 26, P < 0.001; AJ, F1,26= 
24, P < 0.001). There was no effect of competition on proportional gametocyte 
composition of clone AJ (Figure 4.313; F1,26= 0.6, P = 0.44) or of clone AS in C57 mice 
(Figure 4.3C). In CBA mice, however, clone AS (Figure 43C) had reduced 
proportional gametocyte investment in mixed compared to single infections (mouse 
strain* competition interaction: F1,31 = 7, P = 0.011). 
Thus, both covariate and proportional analysis (Figure 43A, B and 4.3C, D) 
revealed the same picture. Competition reduced the number of asexual parasites (Figure 
4.2) and proportionately, the number of gametocytes of clone AJ (Figure 4.3). This was 
also true for clone AS in C57 mice, but not in CBA mice, where there were 
disproportionately fewer gametocytes (Figure 4.2 and 4.3). 
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To evaluate the kinetics of transmission investment, I examined the frequency of 
AS clones in the asexual and gametocyte populations in mixed infections through time 
[number of AS clones/(number of AS clones + number of AJ clones)]. The frequency of 
AS gametocytes closely tracked the frequency of AS asexuals one day earlier (Figure 
4.4; R2 = 0.5 1, F1,58= 62, P <0.001), as expected from 1 day maturation time of P. 
chabaudi gametocytes (Gautret et al. 1996a). This correlation was stronger than the 
correlations with asexuals on the same day, or two or three days earlier. 
Summed over the infection, the proportion of parasites in mixed infections 
which were clone AS was less than 50%, demonstrating higher parasite production of 
clone AJ. The frequency of clone AS in the asexual population in mixed infections was 
greater than the frequency in the gametocyte population (F1 ,29= 50, P < 0.001). This is 
likely because clone AJ produced more gametocytes per asexual parasite than clone AS 
did. Additionally, the frequency of clone AS in the asexual and gametocyte populations 
were higher in CBA compared to C57 mice (Fj,29= 50, P < 0.001). This suggests that 
although both clones produced more parasites in strain CBA compared to strain C57, 
parasite production of clone AS increased by slightly more. Despite this, clone AS 
remained the minority clone in both mouse strains. There were no apparent changes in 
the relationship between proportion of AS gametocytes and total parasites as clone AS 
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Figure 4.3. The relationship between total gametocyte and asexual parasite production. 
Total gametocyte production was compared to total parasite production for each mouse 
alive on day 9 post-infection (A and B). Least squares regression fit lines are given for 
clones AS (A) and AJ (B) in single (solid lines) and mixed infections (dotted lines) in 
C57 (black circles) and CBA mice (grey squares). I also compared percentage of 
parasites that were gametocytes (C and D). Plotted points are mean percentage (± 1 
S.E.M) for clones AS (C) and AJ (D) in single (solid line) and mixed infections (dotted 
line). Overall I found that significantly more gametocytes were produced for a given 
parasite density in CBA compared to C57 mice. Additionally, clone AS had higher 
proportional gametocyte production in single versus mixed infections of CBA mice. 
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Figiiuire 4.4. Proportion of parasites in mixed infections that were clone AS. The 
proportion of AS asexuals (left y-axis, solid lines) and gametocytes (right y-axis, dotted 
lines) were tightly correlated through time in both C57 (black lines) and CBA mice 
(grey lines). Standard error bars (± 1 S.E.M) are given, with values based on days which 
both clones were detected via qPCR or qRT-PCR, and two or more mice were alive, in 
respective treatment groups. 
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4.5. Discussion 
Life history strategies of parasite genotypes during intra-specific competition 
have to my knowledge rarely been examined. In this study I uniquely measured life 
history traits of the rodent malaria Plasmodium chabaudi during conspecific competition, 
to assess the role of within-host replication and transmission investment in shaping the 
overall fitness of genotypes. I observed competitive suppression of total parasite and 
gametocyte production for both the virulent (AJ) and less virulent clone (AS) in mixed 
genotype infections. Despite competitive suppression, the more virulent clone produced 
more total parasites and gametocytes than the less virulent clone, and maintained a 
higher frequency in the parasite population during competition. The mechanism behind 
the observed competitive suppression remains unclear, but could be due to direct 
competition for resources such as red blood cells and glucose, or indirect host-mediated 
competition through strain-transcending immune responses (Hellriegel 1992; Yap and 
Stevenson 1994; Gravenor et al. 1995; Hetzel and Anderson 1996; Buckling and Read 
2001; Almogy et al. 2002; Râberg et al. 2006). 
The in-host competitive suppression I observed is directly translatable to the 
transmission success of individual clones, since the proportion of gametocytes within the 
host closely tracked total parasite population throughout the infection. Overall, both 
clones maintained the same level of transmission stage production throughout the 
infection, with the competitively superior and more virulent genotype having a 10-fold 
higher transmission investment. Therefore, my results do not support the theoretical 
possibility that competitively suppressed genotypes may maintain lower total parasite 
densities in the host and put more resources into transmission (Koella and Antia 1995; 
van Baalen and Sabelis 1995; Antia et al. 1996). On the contrary, in one of the mouse 
genotypes studied, I observed that the competitively inferior clone AS actually produced 
relatively fewer transmission stages when under competitive suppression. 
There are multiple factors which could have contributed to the observed reduced 
transmission investment for clone AS in CBA mice, as a result of competition. One 
possibility is that competitive suppression was simply higher for gametocytes compared 
to asexuals in CBA mice, possibly due to a stronger gametocyte-specific immune 
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response in this mouse strain. This hypothesis is supported by results which typically 
demonstrate lower transmission success from CBA compared to C57 mice (unpublished 
data). Why I did not observe a similar relative reduction in gametocyte investment for 
clone AJ may be due to strain-specific immunity, or simply the greater ability of clone 
AJ to persist in a hostile in-host environment, supported by its general competitive 
superiority (De Roode et al. 2004b; Râberg et al. 2006; Bell et al. In Press). 
Regardless of a transmission investment response by clone AS, it still remained 
the minority and ultimately competitively inferior clone. Phenotypic plasticity in 
transmission investment therefore did not alleviate competitive suppression, as 
envisaged by several theoretical studies, and since this response only occurred in one 
mouse strain, it is unlikely to have a very strong impact on the population genetics of the 
parasite. I cannot rule out the possibility that clones may respond to competition in 
other situations such as the case of super-infection, where phenotypic plasticity for 
transmission investment would be particularly important if the first clone to infect the 
host has a strong advantage (Nowak and May 1994; Hood 2003; De Roode et al. 2005a). 
Genotypic adjustments in commitment towards transmission may also be 
epidemiologically relevant when mixed infections are composed of drug resistant and 
sensitive clones. For example, if resistant genotypes can increase transmission 
investment in competition with sensitive genotypes, in response to environmental cues, 
and maintain higher fitness, it could enhance the spread and evolution of drug resistance 
(Buckling et al. 1999c; Hastings and Donnelly 2005). 
My results suggest that competition in malaria infections selects for fixed 
strategies that increase parasite growth rates, virulence, and competitive abilities; rather 
than plasticity in growth or transmission stage production. Thus, this study supports 
current literature which predicts that conspecific within-host competition will result in a 
competitive advantage and positive selection for virulent genotypes and the evolution of 
virulence (Nowak and May 1994; van Baalen and Sabelis 1995; Ebert 1998; Mosquera 
and Adler 1998; Mackinnon and Read 1999b; Read and Taylor 2001; Brown et al. 2002; 
Davies et al. 2002; Hood 2003; Schjorring and Koella 2003; Bell et al. In Press). 
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5. COMPETITIVE FACILITATION OF DRUG RESISTANCE 
IN MIXED CLONE MALARIA INFECTIONS 
5.1. Abstract 
The infection kinetics of resistant and sensitive genotypes co-circulating in the 
same host plays a critical role in the evolution of malaria drug resistance. In particular, 
the timing of drug treatment and level of clearance of the sensitive clone will impact the 
subsequent competition dynamics and therefore the performance of the resistant clone. 
In this study I competed a drug resistant and sensitive clone of the rodent malaria 
Plasmodium chabaudi and applied, at the onset of clinical symptoms, three drug 
treatment regimes: full, half, and quarter-duration of the recommended dosage. I 
observed that under full and half treatment the drug resistant clone experienced 
competitive facilitation, in that it produced more total parasites and transmission stages 
in mixed infections than when initiated as a single infection. Reducing drug treatment to 
a quarter-duration resulted in the competitive release but not facilitation of the resistant 
clone, likely due to the preservation of the sensitive clone and maintenance of within 
host competition. My results suggest that optimal drug treatment strategies for slowing 
the evolution of resistance may be to reduce drug treatment to levels which alleviate 
clinical symptoms in the host, but do not completely clear sensitive parasites. This 
contradicts current thinking on the subject, which asserts that incomplete drug 
treatments will accelerate the rate of resistance evolution. 
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Resistance in human malaria parasites against almost all anti-malarial drugs is 
now well documented and in most cases rapidly evolved within a few years of first 
deployment of treatment in the field (Hyde 2005). Evidence is building that the speed at 
which drug resistance spreads is shaped by the fitness of resistant mutants in relation to 
wild type drug sensitive strains (Hastings and Donnelly 2005). Intra-host dynamics are 
likely to play a particularly critical role in shaping this fitness relationship, due to the 
high genetic diversity of malaria infections and frequent co-circulation of resistant and 
sensitive genotypes in the same host (Babiker et al. 1999b; Anderson et al. 2000; 
Awadalla et al. 2001; Jafari et al. 2004). Additionally, there is now strong experimental 
and indirect epidemiological support that in-host competition between genotypes shapes 
malaria parasite population structure (Daubersies et al. 1996; Mercereau-Puijalon 1996; 
Arnot 1998; Paul et al. 2004b; De Roode et al. 2005b; Hastings 2006; Bell et al. In 
Press). 
Recent studies have shown that resistant malaria clones have lower fitness and 
are competitively inferior in the absence of drug treatment compared to sensitive clones, 
likely due to a resource cost of the resistance phenotype (De Roode et al. 2004a; 
Hastings and Donnelly 2005; Walliker et al. 2005). This cost is believed to be 
outweighed by the fitness advantage resistant clones experience under drug treatment. 
However, the level of this fitness advantage is not explicitly clear in that resistant clones 
could perform in different ways after the drug clearance of sensitive clones, greatly 
influencing the rate in which drug resistance evolves (Hastings and D'Alessandro 2000). 
It is often assumed that in mixed genotype infections, resistant clones will fill the 
space provided by the drug clearance of sensitive clones in a mechanism of competitive 
release (Hastings and D'Alessandro 2000), and indeed this has been observed in studies 
with prophylactic drug treatment (De Roode et al. 2004a). However when individuals 
seek medical attention at the onset of clinical symptoms, parasites will be at higher 
densities in the host and immune function as well as host condition may play an 
important role in shaping infection dynamics (Gupta and Anderson 1999). 
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The presence of parasites for several days before drug clearance of the sensitive 
clone, may allow the immune system to become primed and suppress the competitive 
release of the resistant clone (Cravo et al. 2001). Alternatively, if there is a lag between 
drug clearance of the sensitive genotype and an immune response directed towards the 
resistant genotype, it could result in a period of unchecked enhanced growth for the 
resistant clone (Almogy et al. 2002). 
Ultimately, the performance of the resistant clone will depend heavily on the 
level of clearance of the sensitive clone and the rate of re-infection. This is particularly 
important when considering that both failure to complete drug treatment regimes and 
exposure to infectious bites soon after treatment ends are frequent in the field, likely 
resulting in the persistence of sensitive clones in the infection. If the persistence of 
mixed infections maintained in-host competition, this competition could potentially 
inhibit the release and fitness advantage of resistance clones, observed with prophylactic 
drug treatment (De Roode et al. 2004a). This is supported by the observation that the 
percentage of resistance alleles has stabilized well below the predicted 100% level in 
many endemic malaria regions (Hastings 2006). In theory, drug treatment should result 
in a higher proportional composition and higher fitness of resistant clones compared to 
drug cleared sensitive clones. However, the response resistant clones elicit could lead to 
different outcomes in that suppression, release, or enhanced growth, will vary 
dramatically in the overall numbers of resistant genotypes produced, and their 
epidemiological impact on the evolution of resistance (Hastings and D'Alessandro 2000). 
Here I investigated the dynamics of a drug resistant clone in competition with a 
drug sensitive clone of the rodent malaria Plasmodium chabaudi, after four, two, one or 
zero days of pyrimethamine treatment. Infected hosts were treated at the onset of 
clinical symptoms to mimic a natural field situation of individuals seeking medical 
attention after illness occurs. The dynamics of each clone was monitored individually 
using qPCR for total parasite production and qRT-PCR for transmission stage 
production. 
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I found that drug clearance of the sensitive clone, after four and two days of anti-
malarial treatment, resulted in enhanced growth of the resistant clone, which 
experienced elevated total parasite and transmission stage production compared to its 
performance alone. One day of drug treatment only partially cleared the sensitive clone 
and subsequently, the resistant clone performed as well but not better than it did in 
single infections, therefore demonstrating competitive release but not competitive 
facilitation. 
My findings suggest that reducing drug treatment to levels which just alleviate 
clinical illness and reduce, but do not attempt to eliminate the infection, may be the best 
strategy for slowing the spread of drug resistance, by maintaining in-host competition. 
This contradicts current theory that ascertains incomplete drug treatment will accelerate 
drug resistance evolution which, to my knowledge, has not been previously 
experimentally investigated. 
53. Methods 
5.3.1. Parasites and hosts 
A pyrimethamine resistant Plasmodium chabaudi clone and a genetically distinct 
pyrimethamine sensitive clone were used for this study. Both clones were originally 
isolated from thicket rats Thamnomys rutilans (Beale et al. 1978). The drug resistant 
clone was derived from ancestral clone AS, which was subjected to pyrimethamine drug 
selection during several rounds of concurrent serial passage to evolve drug resistance, 
becoming clone ASpyr-1B, herein referred to as clone R. The drug sensitive clone, 
herein referred to as clone S, was derived from ancestral clone AJ and has been 
subjected to very few serial passages so as to maintain its original phenotype. Both 
clones have been extensively investigated in the experimental literature and clone R is 
known to have lower in host total parasite production, competitive ability and virulence 
compared to clone S (De Roode et al. 2004a; De Roode et al. 2005b; Walliker et al. 
2005). 
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This study consisted of two separate experiments. In both experiments, mice 
were inoculated with 106 S,  106  R, or 106 S+  106  R parasites (2 x 106  total parasites), in 
order to compare the dynamics of each clone when it is alone versus in the presence of a 
competitor (see Table 5.1 for sample sizes) . Parasites were inoculated into 6 - 8 week 
old female mice by diluting singly infected donor mouse blood in 0.1 ml of calf serum 
solution which was injected into the intraperitoneum, as described elsewhere 
(Mackinnon and Read 1999a). Mice were kept on a 12:12 h light-dark cycle and fed on 
41B maintenance diet (Harlan, U.K.) with 0.05% para-amino benzoic acid supplemented 
drinking water to enhance parasite growth (Jacobs 1964). Different mouse strains were 
used for experiment I and H due to high disease severity and host mortality observed in 
CBA mice during experiment I (Table 5.1). 
5.3.2. Drug treatment 
In an effort to mimic the natural field scenario of sick individuals seeking 
medical treatment upon the onset of clinical symptoms, anti-malaria drug treatment 
began on day 7 post-infection, after mice first showed signs of weight loss and anaemia. 
The malaria antifolate drug pyrimethamine was dissolved in DMSO and 100 tl 
administered orally by gavage at a concentration of 8 mg/kg of mouse body weight, 
previously shown to clear all AJ parasites after four days of treatment (Richard Culleton, 
personal communication). Mice either received zero, one, two or four days of drug 
treatment as outlined in Table 5.1. All mice, including negative controls, received a 
gavage of 100 il DMSO on each treatment day. The drug treatment regime 
administered allowed me to monitor the performance of the resistant clone upon 
complete (experiment I) and partial drug clearance (experiment II) of the sensitive clone. 
Drug treatment in experiment H resulted in some mouse death which was determined 
through post-mortem to have been gavage-induced. These mice were dropped from all 
figures and analyses (Table 5. 1), and prevented the analysis of malaria induced mortality 
in experiment II. 
These two clones are the same clones used in Chapter 4, there labeled AS (resistant) and AJ (sensitive). 
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Table 5.1. Mice in each treatment group from experiment I and II. Values given are 
final number of mice used for analysis with the corresponding numbers in brackets 
representing the mice which were excluded due to death (left value), or failed 
inoculation (right value). Some treatment groups were not carried out in both 
experiments as shown by empty cells. Figures for experiment I of red blood cell (Figure 
5.1) and parasite density (Figure 5.3) through time, track some mice which later died and 
were excluded from the analysis, as death was believed to be parasite induced. All mice 
that died in experiment II were excluded from all figures and analysis since the majority 
of death was gavage induced. 
DRUG TREATMENT (DAYS) 
EXPERIMENT Clone 0 1 2 4 
I 
R 7[13+O] - - 5[14+1] 
S 
(CBA/ca mice)  
O[18+2] - - 9[9+2] 
R+S 3 [16 + 1] - - 4 [13 + 3] 
II 
R 2[9+O] 5[5+1] 4[7+5] - 
S 
(C57b1/6J mice)  
3[8+l] 5[7+O] 6[8+4] - 
Ri-S 2[10+0] 5[6+1] 7[11+0] - 
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5.3.3. Monitoring infection dynamics 
To assess parasite virulence, mouse red blood cell density was measured daily 
using flow-cytometry (Coulter Electronics), with a baseline taken one day prior to the 
start of infection. Clone-specific parasite density of clones S and R, in single and mixed 
infections, was monitored using qPCR on parasite DNA extracted from 5 il of whole 
blood taken each day of sampling, as detailed elsewhere (Bell et al. In Press). 
Transmission stage densities were monitored for clones S and R, in single and mixed 
infections, using clone specific qRT-PCR on gametocyte RNA extracted from 20 p1 
(experiment I) or 10 il (experiment II) of blood, as previously described (Chapter 2 and 
4). Since typically less than 1% of qPCR counts reflect gametocyte densities, for clarity 
I refer to counts derived from qPCR as asexual densities and counts from qRT-PCR as 
gametocytes. 
Sampling began on day 3 (experiment I), or day 2 (experiment II), post infection 
and occurred daily till day 17 for experiment I (day 3 and 9 - only qPCR taken; 4,8,11, 
and 15 - no sample taken) and day 21 for experiment II. In experiment II, qRT-PCR for 
gametocytes was only performed from day 12 onwards, after asexual parasites of the 
sensitive clone reached their lowest densities from drug treatment. Quantification with 
qPCR made it possible to back calculate the exact number of parasites injected into the 
host and confirm the inoculation accuracy. Any mice which were found to have 
received less than 106  parasites were dropped from the analysis (Table 5.1). 
5.3.4. Statistical analysis and trait definition 
The effects of competition and drug treatment on infection virulence, parasite 
growth, and transmission investment, were examined using general linear models 
(GLM). For all GLM analysis maximal models were tested and non-significant terms 
dropped to obtain the significant minimal model. Experiments I and II were analysed 
separately due to a not fully factored experimental design (Table 5.1). Where necessary, 
data was log (counts) or arcsin-square-root transformed (proportions) to meet 
assumption of normality and homogeneity of variance. 
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To assess virulence through GLM, I analysed mean red blood cell density after 
drug treatment as a response variable with initial red blood cell density as a covariate. 
The explanatory variables included 'drug treatment' (zero, one, two, or four days of 
drugs) and 'infection type' (S alone, R alone, or mixed). Higher virulence was defined 
as lower red blood cell density. Virulence in experiment I, was further assessed using 
chi-square tests on the number of mice found dead in cages, between the treatment 
groups (does not include euthanized mice). 
To quantify competition dynamics by GLM analysis, response variables included 
mean parasite density, mean gametocyte density, and mean proportion of total parasites 
which were gametocytes; all of which were calculated after the period of drug treatment. 
The performance of each clone was then analysed with explanatory variables 'drug 
treatment' (zero, one, two, or four days of drugs), 'parasite clone' (R or S), and 
'competition' (clone alone or in mixed infection). Competitive suppression was defined 
as a reduction in total in-host parasite production by a clone in mixed infections 
compared to single infections. 
5.4. Results 
5.4.1. Virulence 
Generally, drug treatment reduced virulence, but a longer duration of treatment 
did not result in greater alleviation of clinical symptoms. 
5.4.1.1. Ex  øeriment I 
I found no significant differences in host mortality between treated or untreated 
single infections of clone R (10% untreated, 25% treated), or mixed infections (30% 
treated, 30% untreated). Higher host death was observed for untreated clone S 
infections (50%), compared to treated (5%) infections (2 = 15.5, P = 0.002, d.f. = 3), 
suggesting that virulence was reduced due to drug clearance of the sensitive clone, but 
only when the drug resistant clone was not present. 
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As a further measure of virulence I examined the average red blood cell density 
after completion of drug treatment (Figure 5.1 and 5.2). Four days of drug treatment in 
experiment I appeared to reduce the virulence of single infections of the sensitive clone 
(Figure 5. 1), but I could not test this statistically because the untreated mice died. 
When examining mixed and single resistant clone infections (Figure 5.1 and 5.2A), I 
found no differences in red blood cell loss in the absence of drug treatment (infection 
type main effect: F2,16= 2. 1, P = 0. 165), or any evidence of alleviated virulence due to 
four days of drugs, for either infection type (drug treatment main effect: F2,15 = 0- 1, P = 
0.9). 
5.4.1.2. Experiment II 
In experimental block II there was greater red blood cell loss from single 
sensitive clone and mixed infections, compared to single resistant clone infections, in the 
absence of drug treatment (Figure 5.1 and 5.2B). One day of drug treatment resulted in 
a significant alleviation of red blood cell loss, in both mixed and single infections of the 
sensitive clone (Figure 5.2B). Red blood cell loss was further alleviated in single 
sensitive clone infections as a result of two days of pyrimethamine, but not in mixed 
infections (Figure 5.2; drug treatment*infection type interaction: F4,29 = 4.5, P = 0.006). 
Therefore, although drug treatment reduced the virulence of mixed infections, higher 
drug dosage did not provide any further reduction in host morbidity. Interestingly, red 
blood cell loss appeared to be highest for clone R after 1 day of drug treatment (Figure 
5.1 and 5.2B), but when analyzing clone R individually, this difference was not found to 
be significant (P> 0.1). 
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Figure 5.1. Mean red blood cell loss (± 1 S.E.M) throughout the infection (RBC density 
each day - initial RBC density). Lower values correspond to greater virulence. In 
experiment I the red blood cell loss of single resistant (A), single sensitive (B) and 
mixed clone infections (C) are shown after zero (solid black line) or four days (dotted 
black line) drug treatment. In experiment II (D, E, F) the red blood cell loss of the three 
infection types are shown after zero (solid black line), one (grey line), or two days 
(dotted black line) drug treatment. The black bars above the x-axis represent the time 
period on which drug treatment was given. Standard errors were calculated from all 
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Figure 5.2. Red blood cell density after drug treatment. Lower values indicate greater 
red blood cell loss and higher virulence. In experiment I (A), drug treatment had no 
effect on the anemia induced by either single (solid grey line), or mixed infections 
(dotted line), of the resistant clone. The anemia induced by the sensitive clone could not 
be assessed due to high mortality in clone S infections, without treatment. In experiment 
11(B), drug treatment reduced the virulence of single infections of the sensitive clone 
(black lines), and mixed infections (dotted line), having no effect on single infections of 
the resistant clone (grey line). Points represent the least-squares-mean of log 
transformed red blood cell density (± 1 S.E.M) calculated over days 12-14 (experiment I) 
and days 12-21 (experiment H), from the mice surviving through the sampling period in 
each treatment group (see Table 5.1). 
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54.2. Parasite growth dynamics 
Generally, drug treatment cleared the sensitive clone, releasing the resistant 
clone from competition. The resulting dynamics of the resistant clone then depended 
heavily on the drug treatment regime. 
5.4.2.1. Experiment I 
Four days of pyrimethamine treatment in experiment I completely cleared the 
sensitive clone in both single and mixed infections (Figure 5.3C, D). I observed a one 
day lag between asexual and gametocyte drug clearance (Figure 5.3D), as predicted by 
gametocyte resistance to pyrimethamine and their 8-16 hour half-life (Reece et al. 2003). 
The performance of the sensitive clone in the absence of drug treatment could not be 
assessed, due to the complete mortality of mice harbouring single infections before the 
end of the analysis period (Table 1 and Figure 5.3). 
The resistant clone experienced competitive suppression in the absence of drug 
treatment, resulting in the production of fewer asexual parasites in mixed compared to 
single infections (Figure 5.3A, B and 5.4A). Drug clearance of the sensitive clone 
released the resistant clone from competition, resulting in a higher number of asexual 
parasites and gametocytes (Figure 5.3A, B and 5.4) than it produced in treated single 
clone infections (competition*drug  treatment interaction, asexuals: F1,15 = 4.5, P = 0.05; 
gametocytes: F1 , 15 = 6, P = 0.03). This observed competitive facilitation was not 
attributed to a direct physiological effect of pyrimethamine, since drug treatment did not 
influence the resistant clone when it began the infection in the absence of the sensitive 
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Figure 5.3. Parasite density growth curves of experiment I. Asexual density from 
qPCR (black lines) and gametocyte density from qRT-PCR (grey lines), are given for 
the resistant (A and B) and sensitive clone (C and D), in single (solid line) and mixed 
infections (dotted line). Drug treatment was administered for zero (A and C; sham 
injection), or four days (B and D) from days 7-10, as shown by the black bars below the 
x-axis, with day 12 representing the first sampling point after treatment. All graphs are 
drawn to the same log scale with minimum y-axis value representing the lowest reliable 
detection threshold of qPCR. Mean densities (± 1 S.E.M) were calculated from of all 
mice which were alive on the respective sampling day. 
4 Days drugs 0 Days drugs 




















0 Days drugs 
Figure 5.4. Mean parasite density of drug resistant clone in experimental I. After four 
days of drug treatment the resistant clone produced significantly more asexual parasites 
(A) and gametocytes (B) when in the presence the sensitive clone (dotted line) compared 
to alone (solid line), experiencing competitive facilitation. Data points represent least 
squares mean (± 1 S.E.M) of log transformed total asexual or parasite density over days 
12-14 (asexuals) and 13-14 (gametocytes) post infection, from the mice surviving till the 
end of sampling period (see Table 1). I could not examine parasite or gametocyte 
density of the drug sensitive clone in experiment I, due to complete parasite clearance 
after four days of drug treatment. 
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5.4.2.2. Experiment lI 
One and two days of drug treatment in experiment II greatly reduced but did not 
completely clear both gametocytes and asexuals of the sensitive clone (Figure 5.51), B, F; 
5.61), E, F and 5.7; treatment main effect; asexuals: F2,24 = 31, P <0.001, gametocytes: 
F2,24 = 47, P <0.001). Lower parasite densities were observed in single infections of the 
sensitive clone after two compared to one day of treatment (5.51), B, F; 5.61), E, F and 
5.7; F1,9 = 6.6, P = 0.03), and therefore the combined results from experiments I and II 
suggest higher drug efficacy with increased treatment duration (Figure 5.3 - 5.7). 
Competitive suppression also reduced asexual and gametocyte densities of the 
sensitive clone (5.51), E, F; 5.6D, E, F and 5.7; competition main effect; asexuals: F1,24 = 
19, P <0.001; gametocytes: F1,24= 8.6, P = 0.007), with a suggestive trend of increased 
competitive suppression with drug treatment (Figure 5.7), however, this was not 
significant (drug treatment*competition interaction; asexuals: F2,22 = 2.2, P = 0.14; 
gametocytes: F2,22 = 1.21, P = 0.32). 
Drug treatment regime had a profound affect on the resistant clone in 
competition. In the absence of pyrimethamine, clone R was competitively suppressed 
by the sensitive clone and produced fewer asexual parasites (Figure 5.5A and 5.8), as 
observed in experiment I. After 2 days of drug treatment, the resistant clone was 
released from competitive suppression and then experienced enhanced growth by 
producing more asexual parasites in the presence of the sensitive clone, compared to 
when inoculated as a single infection (Figure 5.5A, C and 5.8). Thus, competitive 
facilitation of the resistant clone was observed both as a result of four (experiment I) and 
two (experiment II) days of drug treatment (Figure 5.4 and 5.8). 
Alternatively, one day of drug treatment did not lead to the enhanced growth of 
the resistant clone (Figure 5.5A, B and 5.8). Instead, clone R produced only as many 
asexual parasites as it did in the absence of competition, but not significantly more, 
therefore demonstrating competitive release rather than competitive facilitation (drug 
treatment*competition interaction; asexuals: F2,19= 6.8, P = 0.006). This suggests that 
the incomplete clearance of the sensitive clone as a result of reduced drug treatment 
maintained in-host competition, preventing the enhanced growth of the resistant clone. 
M. 
Gametocyte density of the resistant clone in experimental block II was difficult 
to assess due to values hovering around the accurate detection threshold of qRT-PCR 
(Figure 5.6 and 5.8). However, in mixed infections it was evident that drug treatment 
resulted in a higher number of gametocytes (treatment main effect, mixed infections: 
F2,13 = 8, P = 0.008), and more gametocytes were produced in drug treated mixed 
infections compared to single infections (Figure 5.6 and 5.8), supporting the enhanced 
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Figure 5.5. Asexual parasite density over the course of infection for experiment II, 
determined by qPCR. The mean densities (± 1 S.E.M) of the resistant (A, B, C) and 
sensitive clone (D, E, F), in single (solid line) and mixed (dotted line) infections, are 
shown for the zero (A, D), one (B, E), and two day drug treatment groups (C, F). Drug 
treatment began on day 7 post-infection, as indicated by the back bars below the x-axis. 
The sensitive clone was cleared by the drugs, with higher drug dosage resulting in lower 
parasite densities (E, F). Two days of drug pressure and high reduction in the density of 
the sensitive clone, resulted in the enhanced growth of the resistant clone in mixed 
infections (C). One day of drug treatment resulted in competitive release but not 
enhanced growth of the resistant clone (B). All figures are drawn to the same log scale. 
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Figure 5.6. Gametocyte density after drug treatment for experiment II, determined by 
qRT-PCR. The mean densities (± 1 S.E.M) of the resistant (A, B, C) and sensitive clone 
(D, E, F), in single (solid line) and mixed (dotted line) infections, are shown for the zero 
(A, D), one (B, E), and two day drug treatment groups (C, F). Drug treatment occurred 
on day 7-9 post infection, before gametocyte density was assessed. Figures for each 
clone are drawn to the same y-axis log scale, and all plots have the same x-axis scale. 
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Figure 5.7. Mean parasite density of the drug sensitive clone after drug treatment, in 
experiment II. Drug treatment resulted in a pronounced reduction of asexuals (A) and 
gametocytes (B), in single (solid line) and mixed infections (dotted line). Points 
represent least squares mean (± 1 S.E.M) of log transformed total parasite density from 
days 12 -21 post infection. Only the mice surviving till the end of the sampling period, 
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Figure 5.8. Mean parasite density of drug resistant clone in experimental II. After two 
days of drug treatment, the resistant clone produced significantly more asexual parasites 
(A) and gametocytes (B) when in the presence of a competitor (dotted line) compared to 
alone (solid line), experiencing competitive facilitation. After one day of drug treatment, 
the resistant genotype performed as well as on its own but not better, experiencing 
competitive release. Points represent least squares mean (± 1 S.E.M) of log transformed 
total parasite density for days 12 -21 post infection. Only the mice surviving till the end 
of the sampling period, were included in the analysis (see Table 5.1). Gametocyte 
density dropped below the accurate level of quantification with qRT-PCR in the single 
infection, zero and two day drug treatment groups. 
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5.4.3. Transmission investment 
Generally, transmission investment was not influenced by drug treatment, for 
either clone. The resistant clone however, had higher transmission investment in 
competition than when alone. 
5.4.3.1. Sensitive clone 
The average proportion of gametocytes produced per total parasites was 
examined as an indicator of transmission investment in response to drug treatment 
(Figure 5.9C). Due to the complete drug clearance of the sensitive clone after 4 days of 
drug treatment, clone S transmission investment could only be assessed in experiment II. 
In the absence of drug treatment, the drug sensitive clone produced more gametocytes 
per total parasites in single versus mixed infections (Figure 5.9C). After two days of 
drug treatment this relationship switched, in that a higher proportion of gametocytes 
were produced by the sensitive clone in mixed versus single infections (drug 
treatment*competition interaction: F2,22 =3.5, P = 0.048). This was primarily due to a 
decrease in gametocyte production per asexual parasite in single infections as a result of 
drug treatment (Figure 5.9C). 
5.4.3.2. Resistant clone 
In both experiment I and lithe resistant clone had higher per parasite gametocyte 
production in competition compared to alone (Figure 5.9A, B); this could only be tested 
formally in experiment I, due to gametocyte values in single infections below the 
detection level of qRT-PCR in experiment II (experiment I: F1,17= 5, P = 0.04). There 
was no significant affect of drug treatment on proportional gametocyte production 
(Figure 5.9A, B, P> 0.1 experiment I and II). Therefore, the resistant genotype 
appeared to increase transmission investment in response to competition but not drug 
treatment. This result is unsurprising considering that clone R is resistant to the 



























Sensitive clone Resistant dlloiriie (F) 
0.8 
0.6 
A - Experiment I 
11 ..... 
......1J 








0 	1 	2 
	
0 	1 	2 
Figure 5.9. Percent of total parasites produced that were gametocytes after drug 
treatment for the resistant clone in experiment I (A) and 11(B), and the sensitive clone in 
experiment 11(C). Four days of drug treatment completely cleared the sensitive clone in 
experiment I, and therefore the percentage of parasites that were gametocytes could not 
be assessed. The resistant clone (A and B) tended to produce more gametocytes per 
parasite in mixed compared to single infections, with drug treatment having no 
significant effect on gametocyte investment. The sensitive clone (C) appeared to 
decrease transmission investment in single infections (solid line), but not mixed 
infections (dotted line) after drug treatment drugs. In experimental II, the single 
resistant clone infection zero and two day drug treatment groups had proportional 
gametocyte values, below the detection threshold of qRT-PCR. Data points represent 
mean (± 1 S.E.M) of total gametocyte density over total parasite density from days 13-
14 (block I) and 12-21 (block H) post-infection. Only the mice which survived till the 
final day of sampling, were included in the analysis (see Table 5.1). 
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5.5. Discussion 
Mixed genotype malaria infections are common in many malaria endemic 
regions, where drug resistant and sensitive genotypes frequently co-circulate in the same 
host (Babiker et al. 1999b; Anderson et al. 2000; Awadalla et al. 2001; Jafari et al. 
2004). Therefore, intra-host dynamics plays a critical role in the evolution of drug 
resistance. In particular, how drug resistant clones respond to the drug clearance of 
sensitive clones is likely to greatly impact the rate at which drug resistance spreads, and 
potentially the population structure of resistance (Hastings and D'Alessandro 2000; 
Hastings 2006). I found that a drug resistant P. chabaudi malaria clone experienced 
enhanced growth upon drug clearance of a sensitive clone, by producing more total 
parasites and transmission stages in mixed infections than when inoculated as a single 
infection. This competitive facilitation of the resistant clone was observed after both 
four and two days of anti-malarial drug treatment, when the highest levels of sensitive 
clone clearance were obtained. Reducing drug treatment to one day led to the 
competitive release of the drug resistant clone, which produced as many asexual 
parasites and gametocytes as it would have done in the absence of competition. 
However, one day of drug treatment did not result in the competitive facilitation of the 
resistant clone, likely due to incomplete clearance of the sensitive clone and the 
maintenance of within host competition. 
The competitive release of the resistant clone observed in this study, in response 
to sensitive clone drug clearance, is similar to results reported after prophylactic drug 
treatment (De Roode et al. 2004a). Most likely competitive release can be attributed to 
the removal of in-host competition for limited resources (Yap and Stevenson 1994). 
Unraveling why competitive facilitation occurred as a result of high drug treatment is 
less obvious and the exact mechanisms in operation here are unknown. One possibility 
is a lag period between drug clearance of the sensitive clone and an immune response 
directed towards the resistant clone. Before drug treatment, it is plausible that the 
immune system is forced to focus on the sensitive genotype due to its representation as 
the majority clone in this phase of the infection. 
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After drug clearance of the sensitive clone there may be a delay in the ability of 
the immune system to recognize the rapid change in the in-host antigenic composition, 
which hinders the elicitation of a specific response targeted towards the resistant 
genotype (Gupta and Anderson 1999). The resistant clone might then experience a 
period of unchecked growth. 
A lag in genotype specific immunity has been observed in HIV infections where 
minority antigenic types are overlooked due to immune commitment to majority 
antigens in the population (Almogy et al. 2002). Antigenic distinction is highly 
plausible in our P. chabaudi system due to the high degree of genetic variation between 
the two clones and evidence from nude mice experiments of an immune mediated 
component to competition (Ràberg et al. 2006). If the delayed immune response 
hypothesis is correct, I would expect that drug clearance of a drug resistant and sensitive 
clone which are antigenically identical, would not result in competitive facilitation, due 
to strong transcending immunity, and may even lead to the prevention of competitive 
release. This hypothesis proves difficult to test explicitly since the qPCR technique, 
which makes it possible to track the growth dynamics of individual clones in 
competition, requires genetic variation for clonal differentiation. 
Regardless of the mechanisms involved, competitive facilitation could be 
predicted in the field due to the common co-circulation of genotypes which are 
genetically distinct. Some suggestive evidence of increased parasite production in 
natural Plasmodiumfalciparum drug resistant infections, after drug treatment, has been 
observed (Robert et al. 2000; Schneider et al. 2006). If occurring, competitive 
facilitation must greatly affect the rate at which drug resistance spreads, likely 
accelerating it beyond current model predictions (Hastings and D'Alessandro 2000). 
Ultimately, this is dependent on how in-host dynamics translates to transmission. In 
general, I found that transmission stage production closely tracked asexual parasite 
production throughout the experiment. Therefore, my results provide a good estimate of 
the transmission success of individual clones and the impact the observed dynamics will 
have on the overall population structure and epidemiology of the parasite (Taylor and 
Read 1998; Mackinnon and Read 1999a). 
Contradictory to previous studies, I found no hint of increased transmission 
investment in response to drug treatment, so that although competitive facilitation 
resulted in increased asexual and gametocyte production, it did not lead to an increase in 
the percentage of parasites that were gametocytes (Buckling et al. 1999a). The 
dichotomy between my findings and those of Buckling et. al. (1999) may be due to the 
different sampling time periods, drug treatment regimes, and P. chabaudi clones studied. 
In particular, here I investigated the response of a clone to drug treatment, which was 
resistant to the drugs and therefore suffered no direct consequences of anti-malarial 
treatment. 
Interestingly, I did find that the drug sensitive clone appeared to decrease 
transmission investment as a result of drug treatment in single but not mixed infections, 
perhaps due to a shift of resources into asexual parasite production, which did not drop 
as dramatically as total gametocyte production (Figure 5.7). The confounding effects of 
competition could have prevented this response in mixed infections. This is supported 
by my observation of a trend of increased transmission investment in response to 
competition, particularly by the drug resistant clone, which is known to suffer the most 
from competition (De Roode et al. 2004a; De Roode et al. 2005b). Although such an 
increased transmission investment response to competition was not observed in my 
previous research (Chapter 4), it is important to consider that here it was measured in 
late stage infections after drug treatment, whereas previously I investigated the response 
over the entire course of infection. 
My results, demonstrating small changes in transmission investment in mixed 
infections, merely further support the conclusion that four and two days of drug 
treatment led to much greater transmission potential of the drug resistant clone in mixed 
compared to single infections. In contrast, after one day of drug treatment transmission 
potential was no higher in mixed compared to single infections. These findings suggest 
that the optimal drug treatment strategy to slow the evolution of drug resistance may be 
to reduce dosages to levels which just alleviate clinical symptoms and prevent host death, 
but do not completely clear sensitive parasites. 
The preservation of sensitive clones will maintain a competition environment 
within the host which should block the competitive facilitation of the resistant clone and 
possibly hinder competitive release. Although zero days of drug treatment 
unsurprisingly results in the most favorable evolutionary outcome of competitive 
suppression, this must be balanced with the health and welfare of the sick host. 
I found that both two and one day of drug treatment reduced host morbidity. 
However, there was no added benefit to increasing drug treatment and mixed infections 
after four days of drug treatment were just as virulent as those left untreated, potentially 
due to the enhanced growth of the drug resistant clone. Therefore, not only did the 
lowest drug dosage provide the most favorable evolutionary outcome, but the greatest 
observed benefit to the host. My findings contradict current theory which ascertains that 
incomplete drug treatment will accelerate the evolution of drug resistance, which to my 
knowledge, has not been experimentally investigated. 
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6. GENERAL DISCUSSION 
6.1. Should we care about gametocytes? 
Predictions about the epidemiology of malaria are often based on in-host 
dynamics rather than transmission. The assumption is frequently made that the 
dynamics observed in the host directly relate to parasite transmission. In this doctoral 
thesis I explicitly sought to test this assumption, asserting that we simply did not have 
enough information to determine how transmission relates to parasite in-host ecology. I 
went on to examine transmission investment in three different contexts: infection 
duration, mixed genotype infections, and drug resistance evolution. I discovered that 
transmission dynamics depend heavily on the context examined. 
In respect to infection duration, I found that gametocyte investment increased in 
long lasting chronic infections. Additionally, during the chronic stage, per gametocyte 
infectivity appeared to be higher. Most importantly, extremely low parasite densities 
that were not detected by microscopy, were infectious to vectors. The typical field study 
using microscopy as a method of parasite detection would therefore have incorrectly 
believed these hosts to be non-infectious; see Schneider et al., 2006. This sheds light on 
why the importance of low level parasite density infections as a transmission reservoir, 
has been grossly underestimated (Bottius et al. 1996; Babiker et al. 1999a; Bousema et 
al. 2006). Therefore, in this context, examining transmission is crucial, as in-host 
asexual parasite densities offer a poor predictor of transmissibility. 
In the context of mixed genotype infections, the link between transmission and 
in-host dynamics was more varied. Conspecific competition was a strong driving force 
of the in-host ecology of acute stage mixed infections 2 . Investigation of transmission 
investment during conspecific competition initially revealed only a small degree of 
phenotypic plasticity in gametocyte production (Chapter 4). Here, one clone was found 
to reduce transmission investment in response to competition, but only in one host 
2  This is likely to be true for chronic infections but was not tested here, for more information see: De 
Roode et. al. 2005b, and Bell et. at. In press. 
genotype. However, in two further experiments (Chapter 5), which utilized the same 
clones as previously examined (Chapter 4), I observed a markedly increased 
transmission investment in response to competition. The conflicting results observed 
between these two chapters were attributed to different sampling periods. This 
suggested that phenotypic plasticity in response to competition can occur and may have 
added temporal variability. Although phenotypic plasticity did not appear to influence 
the overall competitive outcome in any of the situations in which it was observed, it 
would have altered the proportional composition of clones in the vector population 
beyond what was predicted by in-host dynamics. 
It is interesting to note that in all cases where phenotypic plasticity was 
observed during competition, it was elicited by the same competitively inferior clone. It 
is unclear whether this was a consequence of competitive inferiority, or merely a genetic 
trait of clone AS (also referred to as clone R in Chapter 5). Two further experiments to 
test this would be useful: Firstly, an examination of transmission stage production with a 
completely different clonal pair during conspecific competition, ensuring that one clone 
was competitively inferior to the other. Secondly, a competition experiment with the 
competitively superior clone in our study, AJ (also called S in Chapter 5), as the 
competitively inferior clone. It would then be very interesting to observe if clone AJ 
altered its life history and elicited phenotypic transmission investment plasticity. 
Surprisingly, in this thesis I observed no clear alterations in transmission 
investment in response to drug treatment, where they were most expected. Increased 
transmission stage production as a result of pyrimethamine drug treatment has frequently 
been observed, and therefore is likely to play an important role on the epidemiology of 
the parasite (Buckling et al. 1999c; Bousema et al. 2006). However, I do not believe it 
has been examined in the context of conspecific competition, as was done here. It may 
be that competition is simply a more important cue for the parasite. It should be noted 
that a limitation of my study was the short sampling period available for examining 
transmission stage production, due to high host mortality. However, since the bulk of 
parasites were produced in the acute stage I examined, this is where I expected the 
effects on transmission stage production to be most prevalent. 
In general, my thesis provides evidence that transmission stage production can 
vary substantially from the production of in-host asexual forms. Therefore, broad 
epidemiological conclusions based on the in-host dynamics of malaria may by incorrect. 
One could of course take this a step further and ask, do the separate antigenic types of 
each clone, which are produced throughout the infection, differ in their transmission 
investment (Biggs etal. 1991; Su etal. 1995; Antia etal. 1996; Druilhe and Perignon 
1997; Phillips et al. 1997; Snounou et al. 2000; Viney and Read 2002)? It proves very 
difficult to test this hypothesis as it demands a method for distinguishing clonal 
antigenically distinct forms. My results suggest that such a response in malaria is 
unlikely, due to small degree of transmission phenotypic plasticity that was observed 
even at the clonal level. 
6.2. What about mosquitoes? 
There is one important assumption made throughout this doctoral work which 
was not explicitly tested: gametocyte density is positively correlated with vector 
transmission. Generally, studies have found that this is the case (Mackinnon and Read 
1999a). But, ultimately, I only directly measured transmission to vectors in chapter 
three, when examining chronic infections, and there it was observed that per gametocyte 
infectivity to mosquitoes changed throughout the infection. This result suggests that the 
relationship between gametocyte density and transmission might not be straight forward. 
In each subsequent chapter mosquito blood feeds were attempted, but resulted in less 
than 5% of mosquitoes becoming infected. The limited transmission observed did 
portray similar patterns to those observed in gametocytes, but no solid reportable 
conclusions could be drawn. 
It is unclear why transmission was so low in my research whereas previous work 
has observed much higher transmission success of P. chabaudi into the vector A. 
stephensi (Mackinnon and Read 1999a; Ferguson and Read 2004). The poor 
transmission quality of P. chabaudi in this thesis was one of the greatest limitations of 
the rodent malaria system, and it is evident that unknown factors affected transmission, 
which were not occurring in past research. The identification of the natural vector 
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species could potentially alleviate this limitation. There is also ongoing research to 
improve mosquito transmission success of P. chabaudi, by examining the effects of 
factors such as crowding, feeding regime, water cleanliness, age, and temperature. This 
type of investigation could in itself constitute an entire doctoral thesis and prove 
interesting not only from a practical perspective, but also for unraveling vector 
evolutionary ecology and control, which remain poorly understood (Donnelly et al. 2002; 
Scott et al. 2002; Killeen et al. 2003). This however, was not an aim of my doctoral 
research, and gametocyte investigation offers a large stepping stone above the 
transmission knowledge we currently have available. Now we are in a better position to 
begin considering factors that may further shape parasite transmission and epidemiology, 
which revolve around mosquito ecology (Ferguson and Read 2002; Ferguson et al. 
2003). 
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Assessing the relevance and importance of the findings in this thesis heavily 
depends on the reliability of the qRT-PCR technique. During development, qRT-PCR 
was robustly validated against traditional microscope blood smear gametocyte 
quantification. I found a significant 1:1 correlation between these two methods, but the 
R2  value was surprisingly low (Chapter 4). This was likely due to the much greater 
sensitivity and accuracy of qRT-PCR. Previous studies have found that microscope 
smear quantification of gametocytes is subject to a high degree of error due to their low 
densities (Crooks 2004). In essence this makes it very difficult to find a 'gold standard' 
against which to validate qRT-PCR. 
I attempted to reinforce validation with microscope smears by further testing the 
qRT-PCR method against itself, as done in other studies (Witney et al. 2001; Schneider 
et al. 2004). My reasoning was that the technology has been utilized in many contexts, 
with high levels of success, and is in a way its own gold standard (Witney et al. 2001; 
Blair et al. 2002; Cheesman et al. 2003; Munir and Kibenge 2004; Vanlandingham et al. 
2004; Bejon et at. 2005; Bjarnadottir and Jonsson 2005; De Roode et al. 2005a; De 
Roode et al. 2005b; Purcell et al. 2006; Yue et al. 2006; Bell et al. In Press). I therefore 
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quantified gametocytes using two different gametocyte specific genes, pcsl6 and 
pc302249.00.0, under the assumption that the genes were largely independent, and a 
good correlation in the results would provide further support for the validity of the 
method. Indeed a strong correlation was observed. However, although both of these 
genes have been well characterized in P. falciparum and other rodent malaria species 
such as Plasmodium berghei very little proteomics work has been done on P. chabaudi. 
I assumed that the genes are playing functionally similar roles in P. chabaudi due to the 
highly conserved genetics between malaria species (Janse et at. 1994; Vinkenoog et al. 
1995; Canton et al. 1998; Thompson et al. 2001; Carlton et al. 2002; Waters 2002), and 
based on my qRT-PCR results this appears to be the case. 
The ideal test to ensure that both the genes I have used for gametocyte 
quantification are indeed exclusively expressed in gametocytes, would be to isolate 
different life stages of P. chabaudi. Attempts at such purification were made throughout 
my research, using a variety of methods such as gradient purification, and selective 
killing of asexuals with drug treatment. Neither method could ensure 100% pure 
gametocytes. However, a critical discovery during my thesis was that drug treatment 
resulted in rapid reductions in the number of asexual parasites detected by qPCR, with a 
24 hour lag in the reduction of gametocytes detectable by qRT-PCR (Chapter 5). This 
was expected due to the resistance of gametocytes to drugs and their 8-16 hour half-life 
(Reece et al. 2003), thus confirming  that qRT-PCR was indeed quantifying gametocytes. 
Currently, work is ongoing to transfect P. chabaudi with fluorescence protein 
markers (Sarah Reece and Joanne Thompson, personal communication). This 
technology has been utilized previously to purify P. berghei gametocytes, even to the 
level of splitting males from females (Khan et at. 2005). Transfection of P. chabaudi 
has however, proven difficult, but if successful it could provide an alternative method 
for gametocyte purification and quantification, to reinforce my results. Two limitations 
of this method do apply. Firstly, it is much less sensitive than qRT-PCR, and secondly, 
it cannot distinguish between P. chabaudi genotypes, particularly those naturally 
occurring in the host. 
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Genotype differentiation proves to be one of the most difficult hurdles for clone 
specific gametocyte quantification, due to the degree of genetic variation required, even 
using qRT-PCR technologies. In general, gametocyte genes are very highly conserved, 
likely due to their functional importance (Andy Waters, personal communication). The 
gene pcsl6 utilized in this thesis for clone specific gametocyte quantification (Chapter 4 
and 5), was the only one of several tested that exhibited enough variation between clones. 
Since pcsl6 is believed to begin expression in early stage gametocytes, it may not have 
been the obvious first choice; especially considering mature gametocytes are believed to 
contribute the most to transmission (Gautret et al. 1996a; Gautret 2001). The alternate 
gametocyte specific gene pc302249. 00. 0, used for internal qRT-PCR validation during 
my research (Chapter 4), is believed to be expressed in late stage gametocytes and may 
be a more suitable candidate for gametocyte quantification. Currently it is under further 
investigation for clone differentiation, but the assay appears to have a much higher 
gametocyte number detection threshold. 
64. Impact of findings on human malaria epidemiology 
This thesis attempted to not only address some fundamental ecological questions, 
but also relate them to human malaria, so as to provide insights for disease management. 
The types of controlled experiments desired demanded the use of P. chabaudi as a 
model system. As I outlined in the introduction, there are many reasons that make P. 
chabaudi a useful model for the human malaria species, P. falciparum. But it is a model 
and in that regard, is subject to some limitations. I will attempt to address some of these 
limitations here as they directly relate to my research. 
One very fundamental difference between P. falciparum and P. chabaudi is the 
level of parasitemia obtained in the host. P. falciparum is characterized by low 
parasitemia which does not typically rise above 5%, i.e. 10 parasites per .il of blood 
(Field and Niven 1937; Collins and Jeffery 1999). In contrast, I observed P. chabaudi 
infections frequently reaching parasitemia levels in excess of 20%, i.e. 106  parasites per 
p1. This likewise corresponds to different death rates in the natural hosts, which are 
estimated at 0.1 - 1% in humans, and between 5 - 20% in laboratory mice (Drakeley et 
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al. 2000; Breman 2001; Mackinnon and Read 2004; Snow et al. 2005). I raise this point 
here because it may have direct implications for the competition dynamics of the 
parasite. I would expect competition to be greater for P. chabaudi than P. falciparum 
infections, because in the former case crowding is greater and resources, such as red 
blood cells, are more limited. In fact, although there is good epidemiological evidence 
that competition in P. falciparum is occurring, it has not been directly tested, most likely 
for ethical reasons (Daubersies et al. 1996; Mercereau-Puijalon 1996; Arnot 1998; Read 
and Taylor 2001). If competition in P. falciparum does not occur, or even if the strength 
of competition is much weaker than for P. chabaudi, it might exhibit less transmission 
stage production plasticity, because clones may behave more independently. To my 
knowledge, this has not been investigated. 
Similar to overall parasitemia, differences in gametocyte density and prevalence 
are also believed to exist between P. chabaudi and P. falciparum. In my work, I found 
that during the acute phase, P. chabaudi gametocytes were regularly detected in nearly 
all infected hosts, although at low densities. In P. falciparum, gametocyte prevalence 
appears to be much lower, with the number of individuals harboring microscopically 
detectable gametocytes typically below 20% (Taylor and Read 1997). This could partly 
be influenced by the different gametocyte maturation time of 24-36 hours in the rodent 
system, compared to approximately 7 days for the human parasite (Gautret et al. 1996a; 
Eichner et al. 2001; Gautret 2001). Alternatively, this discrepancy could be due to the 
frequent persistence of gametocytes at such low levels in P. falciparum, they are below 
the detection threshold of microscopy (Babiker et al. 1999a; Schneider et al. 2006). 
Despite the underlying cause, gametocytes appear to be a more limited resource for P. 
falciparum. It is difficult to say whether this will make phenotypic plastic responses in 
gametocyte production more important for one species or the other, but it is likely that 
optimized transmission life history strategies for P. falciparum would be critical. 
A further difference between P. falciparum and P. chabaudi, is the importance of 
acquired immunity. Humans in malaria endemic regions are regularly exposed to the 
parasite and therefore have high levels of acquired immunity (Breman 2001), whereas, 
in my work none of the mice were exposed to infection before the start of the 
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experiment. Acquired immunity is likely to have a large impact on in-host competition 
dynamics, especially in the case of clone transcending immune function. Additionally, 
there is evidence that drug efficacy is higher with a primed immune response, which 
could impact the results of my drug resistance studies (Buckling and Read 2001; Cravo 
et al. 2001; Mackinnon and Read 2003). An examination of the effect of acquired 
immunity on the transmission of malaria clones in competition would be very interesting. 
On a final note of the differences between P. chabaudi and P. falciparum, in this 
thesis, for practical reasons I examined in-host competition using only two genetically 
distinct clones. Humans are likely exposed to a multitude of genetic lineages (Babiker 
and Walliker 1997; Arnot 1998; Babiker et al. 1999b; Anderson et al. 2000). I cannot 
conclude that the dynamics here would hold true for all clonal combinations, and what 
would ensue if greater than 2 clones were present has not been experimentally tested 
(see De Roode et al., 2003, for general asexual dynamics). However competition 
dynamics have been observed for a multitude of other P. chabaudi clonal combinations, 
and the addition of more clones in the host is likely to simply increase in-host 
competition (Bell et al. In Press). Likewise, similar transmission investment responses 
might be predicted as those observed here, although they could be more substantial if 
competition is greater. Ultimately, co-infection of 2-3 P. falciparum clones is regularly 
observed in nature (Babiker et al. 1999b) and therefore, my experiments do have 
relevance to the human malaria in host competition environment. 
Despite the limitations of the P. chabaudi model, it does provide insights into 
important phenomena to study in its human counterpart. In particular, many of the same 
technologies that were used here in this thesis could be directly implemented in the field 
to study P. falciparum. Quantification of P. falciparum gametocytes has already begun 
using a real-time quantitative nucleic acid sequence-based amplification technology 
(QT-NASBA), and similar to what I observed, it has shown that densities are regularly 
below the detection threshold of microscopy (Schneider et al. 2004; Schneider et al. 
2006). These studies have also demonstrated that gametocyte densities can persist after 
drug treatment, although in the case of P. falciparum they lasted for several weeks 
(Bousema et al. 2006), whereas, I only observed their persistence for 1-2 days. This 
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discrepancy is likely due to the greater gametocyte half-life of P. falciparum compared 
to that of rodent malaria (Smalley and Sinden 1977; Eichner et al. 2001; Reece et al. 
2003). Most interestingly, the QT-NASBA technology has revealed that some anti-
malarial drugs result in a decrease in gametocyte densities, while others do not 
(Bousema et al. 2006). This is congruent with the findings of Buckling et al. (1999) 
who observed that some types of anti-malarial drugs increase gametocytogenesis in P. 
chabaudi and others do not. These results suggest that different drug types may vary in 
their influence on the dynamics and fitness of drug resistant clones, and therefore their 
impact on the rate of resistance evolution (see Chapter 5). 
A current limitation to the field QT-NASBA technology is the inability to 
distinguish between P. falciparum clones. Clonal differentiation could easily be 
implemented with the qRT-PCR technique I have developed (Chapter 2 and 4), to assess 
the dynamics of individual clones in natural human P. falciparum infections (Decuypere 
et al. 2003). This would require the sequencing of P. falciparum clones regularly 
circulating in humans, and could lead to the missed detection of some lineages. Other 
practical limitations must also be borne to mind. Most notably the high cost of qRT -
PCR and the rapid degradation of RNA in a hot environment, both of which can be 
hindering factors to field work in malaria endemic regions. Despite this, the technology 
should make huge advances for the field of human malaria epidemiology, especially in 
the context of drug resistance evolution. 
6.5. A few burning questions 
Science is the process of discovery, with each answer, come a host of new 
questions. The results I have obtained in this doctoral thesis, likewise, raise many 
questions and my aim here is to suggest possible avenues of future research. 
1. Do chronic infections contribute significantly to the reservoir of human malaria? 
There is growing evidence that low level chronic P. falciparum infections are 
transmissible to vectors (Hamza Babiker, personal communication, Bousema et al. 
2006). Using the techniques I have outlined, it is now possible to quantify gametocytes 
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in chronic and acute P. falciparum infections and compare their infectivity. This could 
provide insights into the mechanism behind the transmission of extremely low parasite 
densities. It would also then be possible to provide an accurate estimate of what 
percentage of the P. falciparum transmission reservoir is maintained in chronic 
infections. 
What is the epidemiological relevance of transmission investment plasticity? 
Although, the transmission investment plasticity responses I observed were very 
weak, they were unexpected and warrant further investigation, as some key questions 
remain unanswered. In particular: How much does this plastic response actually effect 
the transmission of the parasite? What dynamic is observed when the infection is made 
up of more than two clones? Is there a genetic component to this variation? Does P. 
falciparum alter gametocyte production? Does plasticity have an impact on the 
evolution of virulence? Mosquito vector transmission experiments are warranted here. 
Does competitive facilitation, as a result of drug treatment, impact the rate of 
resistance evolution? 
This is an area of research which is just beginning to blossom. An array of 
hypotheses remain to be tested, for which the qPCR and qRT-PCR methods prove to be 
a powerful tool. First and foremost, what is the mechanism behind this response? Is the 
response genotype dependent? Will different types of drugs elicit a different response 
due to their varied mechanisms of operation? Will we observe the same response in P. 
falciparum? As far as I know, this type of dynamic has never been fitted into model 
simulations, therefore, how does it impact the theoretical predictions of resistance 
evolution? 
Can we harness in-host ecology to slow resistance evolution? 
The experiments in chapter 5 suggest that reducing drug treatment maintained in-
host competition, thereby inhibiting the performance of the drug resistant clone. 
However, competitive release was ultimately still observed, and therefore, resistance 
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evolution would be expected. It would be very interesting to investigate if further 
reductions in drug treatment could maintain in-host competition to such a degree, that 
the resistant clone remained competitively suppressed, inhibiting its transmission. 
Balancing this drug treatment regime with the welfare of the host must also be 
considered. This type of investigation has perhaps the most critical relevance to malaria 
control. 
6.6. Concluding remarks 
In this doctoral thesis, I took a step back, and attempted to tap into fundamental 
natural selection principles for the study of parasite evolution. Transmission is the most 
critical driving force for parasite fitness and demands further investigation from an 
evolutionary ecology perspective, if successful malaria control strategies are to be 
achieved. My research provided clues into the dynamic nature of transmission, and 
brought to question the validity of assumptions between observed in-host ecology and 
transmission dynamics. Ultimately, both in-host ecology and transmission shape each-
other: higher levels of transmission increase mixed infection rates. The goal here was 
not to provide all the answers, but rather to raise some important questions that may 
have never been asked. Malaria is a challenging beast, which has proven difficult to 
tame. Each summit we reach only reveals how many more there are left to conquer, but 
it's that final Mt. Everest on the distant horizon that makes the journey worth taking. 
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Abstract 
We have developed two reverse transcription polymerase chain reaction (RT-PCR) techniques to detect and quantify the transmission 
stages (gametocytes) of Plasmodium chabaudi malaria parasites. Both the qualitative and quantitative techniques are based on the ampli-
fication of mRNA coding for the P. chabaudi protein Pcs230, which is expressed exclusively in gametocytes. The quantitative RT-PCR 
(qRT-PCR) technique was developed and validated by examining serial dilutions of known gametocyte densities. The method generated 
a high correlation between calibration curves of blind samples (R 2 = 0.86). The technique was found to be specific, reproducible, and time 
efficient for quantification of both patent and sub-patent gametocytemia with a sensitivity level 100-1000 times greater than microscopy. 
The qualitative RT-PCR (RT-PCR) technique was used to monitor the persistence and dynamics of P. chabaudi gametocytes following 
acute infection. Mice in two independent experiments were sampled for up to 87 days post-infection. RT-PCR showed that gametocytes 
can persist for up to 8 weeks, post-infection, whereas microscopy could only detect gametocytes up to 6 weeks. Potential applications of 
the above techniques for studying the ecology, evolution, and epidemiology of malaria transmission are discussed. 
© 2005 Elsevier Inc. All rights reserved. 
Index Descriptors and Abbreviations: Plasmodium chabaudi; Gametocyte; Malaria transmission; pcs230; Chronic infection; DNA, deoxyribonucleic acid; 
RNA, ribonucleic acid; dNTPs, deoxyribonucleotide triphosphate mix; RT-PCR, reverse transcription of the RNA followed by PCR amplification of the 
eDNA; cDNA (RNA to complementary DNA); qPCR, quantitative real time PCR; qRT-PCR, quantitative real time reverse transcription PCR 
1. Introduction 
Molecular methods are now becoming widely utilized to 
study malaria parasites both in field and laboratory set-
tings. The power of these techniques is increasingly clear, 
particularly for studying the ecology and evolution of para-
sites. In nature, malaria infections often occur at sub-patent 
levels where parasites cannot be detected by microscopy. 
This is very common in areas such as eastern Sudan, where 
the transmission of Plasmodium falciparum is highly sea- 
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sonal and chronic sub-patent infections are prevalent in the 
dry season (Abdel-Wahab et al., 2002; Babiker and Walli-
ker, 1997; Hamad et at., 2002). 
Numerous studies have been conducted to examine the 
diversity and dynamics of asexual forms of malaria para-
sites, but the ecology of gametocytes is still poorly under -
stood. Recently, reverse transcription PCR (RT-PCR) 
techniques have been used to detect RNA of proteins that 
are expressed exclusively in gametocyte stages, distinguish-
ing gametocytes from asexual stages of P. falciparum, even 
At sub-patent levels (Babiker et at., 1999; Menegon et at., 
2000; Niederwieser et al., 2000; Schneider et at., 2004). 
Some gametocyte-specific protein genes are polymorphic, 
allowing the technique to be extended to distinguish game- 
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tocytes of different genotypes within a single infection 
(Abdel-Wahab et al., 2002). RT-PCR has shown that P. fal-
ciparum is capable of producing gametocytes, even when it 
exists as asymptomatic, sub-patent infection, demonstrat-
ing the potential of such infections to sustain the cyclical 
malaria epidemics in areas of seasonal transmission (Babi-
ker et al., 1999). A shortcoming of the existing RT-PCR 
protocol is that it cannot quantify gametocytes (Abdel-. 
Wahab et al., 2002; Babiker et al., 1999, 2000; Menegon 
et al., 2000). Such quantification is important to gain a bet-
ter understanding of the transmissibility of individual para-
site clones that exist in mixed clone infections and the 
ecological factors that influence them. 
Recently, real-time quantitative PCR (qPCR) has been 
developed and successfully utilized to study the dynamics 
of different malaria species and genetically distinct clones in 
mixed infections (Cheesman et al., 2003; De Monbrison 
et al., 2003; De Roode et al., 2004; Perandin et al., 2004). 
This method enables accurate quantification of genomic 
DNA of specific malaria parasite clones within multiple 
infections, but cannot selectively quantify different life-
stages. However, quantitative reverse transcription PCR 
techniques (qRT-PCR) have also been developed and uti-
lized for the quantification of RNA coding for various 
genes, including those of malaria parasites (Bruna-Romero 
et al., 2001; Nirmalan et al., 2002). The technique has been 
utilized for the quantification of malaria parasite liver 
stages and a related but different method (QT-NASBA) has 
been used to examine dynamics of P. falciparum gameto-
cytes (Schneider et al., 2004; Witney et al., 2001). 
We report here on the utilization of PCR and RT-PCR 
protocols to detect parasites and monitor the longevity of 
Plasmodium chabaudi infections and their gametocyte pro-
duction over time. Additionally, we developed RT-PCR 
and qPCR methods into a protocol for qRT-PCR that can 
specifically quantify gametocytes of the rodent malaria par-
asite P. chabaudi. 
2. Materials and methods 
2.1. Plasmodium chabaudi infections 
Two independent experiments were carried out to moni-
tor the longevity of gametocyte production of the P. chab-
audi rodent malaria parasite clone CR that is known to 
have moderate virulence in mice (Mackinnon and Read, 
1999). Infections were established by inoculating 5 (experi-
ment I) and 10 (experiment II) C57B1/6J 5 to 8-week-old 
inbred female mice (Harlan Scientific, UK) with 106  P. 
chabaudi parasites, into the peritoneal cavity, as described 
elsewhere (Mackinnon and Read, 1999). Mice were main-
tained at 21 °C (±1 °C) and fed ad libitum SDS 41B (Har-
lan Scientific, UK) rat and maintenance diet and 0.05% 
PABA supplemented drinking water to enhance parasite 
growth. Blood samples (10 j.tl for DNA extraction and 20 i.tl 
for RNA extraction), thin blood smears, and red blood cell 
counts (on 2 p1 of blood) from flow-cytometry (Coulter 
Electronics) were taken 5 days a week, for 3 weeks, starting 
on day 3 post-infection (PT). After day 22 P1, samples were 
taken 2-3 times a week until day 87 (experiment I) or day 
70 (experiment II). Larger blood volumes were required for 
RNA extraction to increase sensitivity for gametocytes 
which are in low abundance compared to asexual stages. 
Thin blood smears were stained with a 20% Giemsa solu-
tion and examined under a microscope at 1000 x magnifica-
tion to determine parasitemia and gametocytemia. Parasite 
and gametocyte densities were calculated by multiplying 
parasitemia and gametocytemia, respectively, by red blood 
cell density, measured with flow-cytometry. 
For qRT-PCR, separate infections of the P. chabaudi 
clone CR were established in three NIH mice using meth-
ods described above. The density of gametocytes (gameto-
cytemia) was determined using Giemsa stained thin blood 
smears, and blood samples were taken for RNA extraction 
when gametocytes were visible microscopically. These mice 
were not used for the monitoring of chronic infections via 
RT-PCR. 
2.2. Molecular methods for detecting parasites 
2.2.1. DNA extraction 
For general PCR, DNA was extracted from 10 p1 of 
blood taken from the tail of P. chabaudi infected mice and 
added to 200 i.tl of citrate saline (0.85% NaCl, 1.5% tri-
sodium citrate), on ice. The samples were centrifuged at 
11,000 rcf for 2-3 min to pellet red blood cells and the 
supernatant was removed. The blood pellet was stored at 
—80 °C until DNA extraction. DNA was extracted using 
InstaGene Matrix (Bio-Rad) according to the manufac-
turer's protocol. 
2.2.2. RNA extraction 
Parasite RNA was extracted using two methods: 
For RT-PCR, RNA was extracted from 20 p1 of 
whole blood, using TRIzol Reagent for total RNA isola-
tion, according to the manufacturer's protocol (Invitrogen 
Life Technologies). On each day of sampling, 20 j.tl of blood 
was taken from the tail of each mouse and added to 200 j.tl 
of citrate saline on ice. The samples were centrifuged at 
11,000 rcf for 3 min at room temperature to pellet the blood 
and the supernatant was removed. A 10  volume (200 j.tl) 
of TRIzol was added to each pellet and the samples were 
vortexed immediately and stored at —80 °C until RNA 
extraction. RNA samples were subjected to DNase treat-
ment to remove co-extracted DNA in a 10 i.tl reaction con-
taining 5 jtl RNA extract, 5 m Tris, pH 7.6, 33 m 
MgCl2, 0.27 U RNasin Ribonuclease Inhibitor and 4.2 U 
DNase I (Roche, UK), with incubation at 37°C for 15 mm 
and 75°C for 10 min. 
For qRT-PCR, RNA was extracted using the Applied 
Biosystems 6100 equipment and protocols. This method 
allows simultaneous processing of 96 samples and is more 
time efficient for use with the 96-well qRT-PCR format. To 
extract gametocyte RNA, 20 p.1 of blood was taken from the 
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mouse tail and added to 200 iii of citrate saline pre-warmed 
to 37°C to avoid alterations in expression of RNA believed 
to occur at temperature changes (Fang and McCutchan, 
2002). Samples were centrifuged at 11,000 rcf for 3mm at 
room temperature, the supernatant was removed, and 20 j.tI 
Ca2 /Mg2 free RNaselDNase free PBS (Gibco) and 40 t! of 
2x Nucleic Acid Purification Lysis Solution (Applied Bio-
systems) were added to the blood pellet. The samples were 
then stored at -80 °C. For completion of the extraction pro-
tocol, the samples were thawed and incubated at room tem-
perature for 1 h to digest blood. RNA was extracted using 
the Applied Biosystems Isolation of total RNA from Whole 
Blood Chemistry protocol on the ABI Prism 6100 Nucleic 
Acid PrepStation with the RNA Blood-DNA method 
(Applied Biosystems). RNA was eluted in 100 j.tI of Nucleic 
Acid Purification Elution Solution and stored at -80°C 
until required for quantification. 
2.2.3. PCR and RT-PCR 
Primers for PCR and RT-PCR used for longevity exper -
iments were developed to amplify the gametocyte-specific 
P. chabaudi gene pcs230 (GenBank Accession No. 
EAA1 5629.1 and EAA22479.1). The pcs230 sequence was 
determined by the P. chabaudi sequencing project and can 
be obtained from ftp://ftp.sanger.ac.uk/projectsfP.chabaudi . 
This gene belongs to the p_s48145 super-family that encode 
gametocyte-specific surface proteins in malaria parasites 
and is only expressed in mature late stage gametocytes 
(Bozdech et al., 2003; Hall et al., 2005; Le Roch et al., 2003; 
Lobo and Kumar, 1998; Niederwieser et al., 2000; Thomp-
son et al., 2001; Williamson et al., 1993). To increase the 
sensitivity of detection, two rounds of PCR were per-
formed, using outer primers, Pc230(01), 5 '-AAAGATTC 
AGGGCATGGCG-3' and Pc230(02), 5'-TTGCCCCA 
CF1TF1GAGCTAC-3'and inner primers, Pc230(Nl), 5'-AT 
CTGTFATGCCTFATGGGAG-3'and Pc230(N2), 5 '-CTT 
GATIAATACTFAGATACACCATATGAG-3'. The opti-
mal annealing temperature for each set of primers was 
determined on a ThermoHybaid PCR machine using a 
temperature gradient PCR on samples known to be posi-
tive for P. chabaudi DNA. 
To determine longevity of P. chabaudi infection, PCR 
was performed using Roche 2 x PCR Master mix in 20 j.tl 
reactions containing 2 jsl of genomic DNA, 0.5 U Taq DNA 
polymerase, 10 m Tris-HC1, 50 m KC1, 1.5mM MgCl2, 
0.2mM dNTPs, and 0.5 jsM of primers Pc230(01) and 
Pc230(02). Samples underwent PCR on an MJ Research 
DNA Engine, PTC-200; using the following conditions: 
denaturation at 94°C/180s, 35 cycles of amplification 
[94°C/30s, 51 'C/30 s, and 70°C160s], and a terminal exten-
sion at 70°C/600s. Positive DNA controls and negative 
controls (all reagents + 2 p.1 water) were run for each reac-
tion. The outer PCR products were then diluted lOx and 
2 j.tl of the diluted product underwent nested PCR using 
primers Pc230(N1) and Pc230(N2) in a 20 j.tl PCR using 
PCR Master mix (Roche) and the PCR conditions 
described above. 
For the detection of longevity of gametocyte production 
in P. chabaudi infection, a nested RT-PCR was carried out 
to detect pcs230 mRNA. RNA samples underwent a one-
step RT-PCR using the AccessQuick RT-PCR system 
(Promega). This protocol generates cDNA from RNA and 
then amplifies the cDNA through PCR, in a single reaction. 
The RT-PCR was carried out in a 20 i.tl volume on the MJ 
Research DNA Engine PTC-200, with a reaction mixture 
using the AccessQuick Master Mix reagents consisting of 
2 i.tl of RNA, 2 U of AccessQuick reverse transcriptase 
(Promega), 2 U tfl DNA polymerase, 0.2mM dNTPs, 
1.5mM MgCl2, 10 p.1 AccessQuick Master Mix (supplied by 
Promega as part of kit), 0.5 p.M of primers Pc230(01) and 
Pc230(02), and 6 p.1 AccessQuick H 20 (Promega). The RT-
PCR and subsequent amplification of cDNA took place 
under the following conditions, reverse transcription at 
50°C/60min, denaturation at 94°C/3min, 39 cycles of 
amplification [94°C/30s, 61 °C/30s, and 70°C/6s], and a 
terminal extension at 70°C/600s. Simultaneously, an ali-
quot of 2 p.! RNA from each sample was subjected to the 
same PCR protocol using the primers and the above condi-
tions minus reverse transcriptase, to detect any carry over 
genomic DNA that might have been co-extracted with the 
RNA samples. Positive RNA controls, positive DNA con-
trols, and negative controls (all reagents +2 p.1 water) were 
also included in each run. All outer RT-PCR products were 
diluted 1/10 then underwent a second PCR under the same 
conditions as outlined for the PCR of DNA. 
2.2.4. Detection limits of PCR and RT-PCR 
To determine the sensitivity of nested PCR and RT-PCR, 
samples of known parasite and gametocyte density deter-
mined by microscopy (parasites or gametocytes/pi of blood) 
of P. chabaudi were serially diluted. Eight independent sam-
ples of extracted DNA were subjected to 10-fold serial dilu-
tions, creating a dilution series ranging over seven orders of 
magnitude from undiluted (neat) to diluted 1/1 (actual par-
asite density range tested: 1.72 x 10 5-4.3 x 10-3  parasites/p.!). 
Since nested PCR of DNA amplifies genomic DNA from all 
stages of the parasite, counts of both ring stage parasites and 
gametocytes were used to determine parasite densities from 
thin blood smears. To establish the sensitivity of RT-PCR, 11 
samples of RNA were subjected to 10-fold serial dilutions, 
creating a dilution series ranging from neat to diluted 1/10 
for seven samples. None of the samples 1-7 were positive 
below a dilution of 10 5 , so four more samples were diluted 
only to 1/106.  The overall dilution range tested for RT-PCR 
was 1.3 x 10-1.0 x 10 parasites/p.!. 
2.2.5. qRT-PCR 
A qRT-PCR technique was performed to amplify and 
quantify RNA coding for the gametocyte-specific protein 
Pcs230, using the Applied Biosystems TaqMan One-Step 
RT-PCR Master Mix Reagents Kit, on the ABI Prism 7000 
sequence detection system. Two primers (Pc230RT-1, 5'-T 
CTAGTACATGCTTTGAAGAAGTAATAGAATATA 
ATCCTAATA-3', and Pc230RT-2, 5 '-TGCAACGACTT 
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TCTATAGCTAGTAGGT-3') and a fluorescent labeled 
probe (Pc230RT-probe, 5 '-AAAAATGGGATCGAAAT 
AAAA-3') were designed by Applied Biosystems Assays-
by-Design Service from the pcs230 gene sequence. As part 
of this service, Applied Biosystems optimized all primers 
and probe amplification and annealing conditions and 
combined them in a master mix. 
A one-step qRT-PCR assay was used to generate cDNA 
from RNA and the cDNA quantified, in a single reaction 
(Applied Biosystems). This method assumes that reverse 
transcription takes place at a constant rate between all sam-
ples (Nirmalan et al., 2002). The reaction mix consisted of 
8.5 j.tl of extracted RNA, 1 j.il of 20x Assay-by-Design Mix 
containing primers and probes at a reaction concentration 
of 900 and 250 nM, respectively (supplied by Applied Bio-
systems), and the following components from the Applied 
Biosystems TaqMan One-Step RT-PCR Master Mix 
Reagents Kit: 10 j.tl 2x AmpliTaq Gold DNA Polymerase 
mix (contains AmpliTaq Gold DNA polymerase, dNTP's 
with dUTP and buffer components), 5 j.il of 40x RT enzyme 
mix (contains MultiScnbe Reverse Transcriptase and 
RNase Inhibitor). Samples were loaded onto 96-well opti-
cal reaction plates and placed in the ABI Prism 7000 
Sequence Detection System (Applied Biosystems), then 
underwent the following reaction conditions: reverse tran-
scription at 48°C for 30mm, denaturation at 95°C for 
10 mm, and 50 cycles of amplification [95 °C for lSs and 
60°C for 60s]. Data were visualized using the ABI Prism 
7000 SDS Software (Applied Biosystems). Simultaneously, 
eight RNA samples underwent conventional nested PCR 
using primers Pc230(01), Pc230(02), Pc230(N1), and 
Pc230(N2) to test for DNA contamination. 
2.2.6. Validation of qRT-PCR 
The qRT-PCR technique was validated by comparing 
threshold cycle values (number of cycles after which a sam-
ple crosses the threshold of positivity) generated from serial 
dilutions of samples of known gametocytemia. We expected 
the threshold cycle to be negatively correlated with the 
number of gametocytes present in a sample, showing the 
same value when the numbers of gametocytes in two differ -
ent samples are equal. Therefore, a strong correlation in 
best fit lines for threshold cycle versus gametocyte number 
generated from serial dilutions with known numbers of 
gametocytes will demonstrate that gametocytes are accu-
rately quantified. To further test the robustness of the 
method, we compared the accuracy of threshold cycle val-
ues calculated for two different types of serial dilutions, per -
forming replicates of each set. The first set of dilution series 
was prepared blindly with extracted RNA from samples of 
known gametocyte counts (determined after qRT-PCR, via 
microscopy). Eleven, 10-fold serial dilutions (neat to 1/107) 
of extracted RNA (from three different mice) diluted in 
water were prepared. A second type of dilution curves were 
set up blindly to dilute actual parasites by using uninfected 
blood from NIH mice to dilute samples of P. chabaudi 
infected whole blood with known gametocyte counts (num- 
bers calculated after qRT-PCR, via microscopy). Two, 
independent, 10-fold serial dilutions ranging from neat to 1/ 
107 were generated in this manner and the dilution series 
samples were extracted on the ABI Prism 6100 Nucleic 
Acid PrepStation with the RNA Blood-DNA method 
(Applied Biosystems). The dilution of samples with the 
uninfected whole blood method more accurately simulates 
quantification of gametocytes from mice harbouring differ-
ent levels of gametocyte density, and therefore accurately 
demonstrates the sensitivity of extraction as well as qRT-
PCR. 
All 13 sets of RNA dilutions were quantified for pcs230 
mRNA using the TaqMan One-Step RT-PCR Master Mix 
Reagents Kit on the ABI Prism 7000 sequence detection sys-
tem (Applied Biosystems). The data from all curves were 
pooled and analysed using Minitab statistical software (ver-
sion 13.1). Threshold cycle values were regressed against the 
log 10 of the number of gametocytes within samples using 
ANCOVA. All sets of serial dilutions were compared using a 
regression to estimate the validity of the qRT-PCR method. 
3. Results 
3.1. Detection of P. chabaudi infection and gametocytes 
Conventional PCR of genomic DNA showed a mean 
minimum detection limit of 3.68 ± 2.11 (±1 SE) parasites/.tl 
blood. With regard to gametocytes, RT-PCR was found to 
detect a mean minimum of 27.1 ± 11.7 (±1 SE) gameto-
cytes/g] blood. However, in 5 out of 11 sets of serial dilu-
tions of gametocyte-infected blood, qualitative RT-PCR 
was detected down to 1 gametocyte/pi of blood. These 
detection limits are similar to those found for the detection 
of P. falciparum asexual forms and gametocytes (Babiker 
et al., 1999; Roper et al., 1996). In general, the sets of dilu-
tion series that started with initial higher gametocytemia 
resulted in RT-PCR product at lower dilutions (Fig. 1). In 
one case, a neat sample did not give an RT-PCR product, 
likely due to pipetting error. 
Overall, significantly more blood samples were found to 
harbour P. chabaudi infection revealed by PCR (X2 = 16.9, 
P <0.0001, df= 1), and gametocytes detectable by RT-PCR 
( 2 = 24.4, P<0.0001, df= 1), than by microscopy. Across the 
424 blood samples examined, 161(38%) were gametocyte-
positive by nested RT-PCR, whereas only 97 (23 1/6) were 
gametocyte-positive by microscopy. There were 14 instances 
(3.301/o) where gametocytes were detected by microscopy but 
not with nested RT-PCR, likely to be due to failed RNA 
extraction. PCR product from DNA was seen in 110 (27%) 
out of 405 blood samples when RT-PCR for gametocyte 
RNA was negative. Because both gametocytes and asexual 
parasites contain DNA but only gametocytes contain Pc230 
RNA, we believe these samples represent cases where asexual 
parasites were present but gametocytes were absent. Addi-
tionally, it has been shown that PCR of parasite DNA is not 
possible after the parasites have been cleared by the host 
(Jarra and Snounou, 1998). 
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Fig. 1. Detection level of gametocytes with RT-PCR of RNA coding for 
the Pcs230 gene. Each line represents a separate dilution series of indepen-
dent samples. Y-axis shows number of gametocytes in the sample esti-
mated by microscopy. X-axis shows the position of the sample in the 
dilution series with 0 being the neat (undiluted) sample and 7 being the 
seventh dilution in the series (i.e., the neat sample diluted l0 - ). A dilution 
series up to 10 was performed on seven samples and up to 10_6  on four 
samples. Where symbols are present, positive RT-PCR was obtained. 
Where symbols are absent, RT-PCR was negative. In one case, RT-PCR 















3.2. Persistence of P. chabaudi asexuals and gametocytes in 
infected mice from longevity experiments 
Figs. 2A and B show P. chabaudi parasite density in 
chronic infections revealed by microscopy, nested PCR, 
and RT-PCR for one of the five mice in experiment I and 
one of the 10 mice in experiment II, respectively. All of the 
remaining mice in both experiments show the same pattern 
as those in Figs. 2A and B (see Supplementary data). In 
both experiments, gametocytes were often detected using 
RT-PCR several days after they were no longer detectable 
by microscopy. Mice controlled initial parasitemia after 
about 3 weeks. Subsequently, the infections showed one or 
a few transient peaks of patent parasitemia that recru-
desced between days 30 and 60, during which time gameto-
cytes were frequently only detectable by RT-PCR. In most 
mice, parasites were not detected after day 50 P1 and none 
were detectable either by microscopy or molecular methods 
after day 60. The median time (±1 SE) to clearance of 
gametocytes (i.e., time for 50% of mice to clear gameto-
cytes) was 36±3 days derived by RT-PCR compared to 
18±2 days by microscopy (Kaplan-Meier test). 
3.3. qRT-PCR 
The qRT-PCR technique for gametocyte-specific pcs230 
RNA in 13 separate serial dilutions of gametocytes detected 
approximately one gametocyte per reaction, corresponding 
to 1 gametocyte/i.tl blood (Fig. 3). As expected, the number 
of gametocytes was highly related to the threshold cycle 
to 	20 	30 	40 	50 	60 	70 
Day Post Inoculation with Parasites 
Fig. 2. Plasmodium chabaudi asexual forms and gametocytes detected by 
microscopy, PCR, and RT-PCR in a mouse from experiment 1(A) and 
one from II (B). Red solid lines and blue dotted lines represent asexual 
stages and gametocytes density, respectively, as determined by micros-
copy. Squares show qualitative PCR for respective days, filled squares are 
positive samples, empty squares are negative samples, absence of a square 
means no sample taken. Triangles represent qualitative RT-PCR samples 
for Pcs230 gene on respective days, illustrated in the same manner. PCR 
and qualitative RT-PCR were more sensitive for detecting asexuals and 
gametocytes than microscopy as indicated by filled squares and triangles, 
respectively. No RNA samples showed an RT-PCR product when reverse 
transcriptase was omitted, thus excluding DNA contamination during 
RNA extraction. (For interpretation of the references to colour in this 
figure legend, the reader is referred to the web version of this paper.) 
(R2 = 0.86, F1 ,32 = 174, P <0.0001), with no significant differ-
ences in the slope of the relationship between the 13 dilution 
series. Specifically, there was no difference in slope between 
the two dilution series made from samples diluted in whole 
blood and 11 dilution series made extracted RNA diluted in 
water (P> 0.05 in all cases). The common slope (± 1 SE) of 
the combined 13 dilution series was CT= —3.20(±0.24). Our 
results are very close to the optimum obtainable slope of 
—3.3 for PCR amplification during qRT-PCR. 
4. Discussion 
We have previously developed an RT-PCR technique 
to detect RNA encoding proteins that are expressed 
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Fig. 3. Threshold cycle (determined by qRT-PCR) and gametocyte num-
ber (determined by microscopy) for 13 dilution series (11 from diluted 
extracted RNA, 2 from dilutions of actual parasites with whole blood). 
The lines are the least squares regression line (solid) with 95% confidence 
intervals (dotted). There is a strong correlation between threshold cycle 
and gametocyte number (R2 = 0.86, F132 = 174, P <0.0001; slope ± 1 
SE = —3.20 ± 0.24). See text for further details. 
exclusively in P. falciparum gametocytes (Babiker et al., 
1999; Menegon et al., 2000). Here, we have extended this 
protocol and established robust and sensitive RT-PCR and 
qRT-PCR methods to monitor the persistence of P. chab-
audi gametocytes throughout infection. The techniques are 
based on the amplification of pcs230 mRNA, which is 
expressed exclusively in gametocytes (Hall et al., 2005; Nie-
derwieser et al., 2000; Thompson et al., 2001). 
We found that the qRT-PCR detection limit ranged 
from 1 to 10 gametocytes/p.l of blood making it 100-1000 
times more sensitive than microscopy, with similar sensitiv-
ity levels to those found using QT-NASBA for P. falcipa-
rum gametocytes (Schneider et al., 2004). This very low 
limit of detection was reproducible in 11 independent sets 
of serial dilutions of gametocytes. Such very low gameto-
cytemia would require an experienced microscopist to 
examine more than 1000 fields of a well-stained thick blood 
smear, which could take at least 50 min (Babiker et al., 
1999). Additionally, quantification by microscopy is often 
inaccurate when gametocytes persist at the low levels 
(<0.01 gametocytes/red blood cell) common in natural 
malaria infections (L. Crooks, Transmission Investment in 
Malaria, Ph.D. Thesis, University of Edinburgh, 2004; Tay-
lor and Read, 1997). Thus, comparatively, the qRT-PCR 
technique for gametocytes presented here provides a spe-
cific and highly sensitive estimate to gametocyte density, 
especially at low levels of gametocytemia. It is theoretically 
possible that different stages of gametocytes may express 
varying levels of Pcs230 RNA. However, even when using 
blood samples from mice on different days post-inocula-
tion, our results showed a strong correlation between 
expected and observed gametocyte values, showing that 
expression level is not a source of a large degree of error. 
Overall, our protocol is time efficient and capable of pro-
cessing 96 samples in 8 h. It, therefore, has great epidemio-
logical potential, and can easily be adapted to study human 
malaria parasites. This method differs from current quanti-
fication protocols in that it is, to our knowledge, the first to 
quantify P. chabaudi gametocytes. Since this technology 
only requires the design of probes and primers and does not 
require the use of gene constructs as internal standards, 
assays can rapidly and cheaply be developed. In addition, 
by utilizing polymorphic gametocyte-specific protein genes, 
the presented method can easily be adapted for tracking an 
individual gametocyte genotype when the infection is com-
posed of multiple genotypes. Through the application of 
newly described sex specific gametocyte protein genes (e.g., 
Khan et al., 2005), the method can also be developed for the 
individual quantification of male or female gametocytes. 
We used the developed RT-PCR technique to monitor 
longevity of gametocyte production of two P. chabaudi 
clones. Our results demonstrated that P. chabaudi persisted 
at sub-patent levels, and continued to produce gametocytes 
for several weeks as chronic infections. This result agrees 
with that seen in natural P. chabaudi infections in the natu-
ral host Thomnomys rutilans, where chronic infections last-
ing up to 2 years are often observed (Landau et al., 1999). 
In the present study, P. chabaudi infection persisted for up 
to 60 days post-infection, however, the duration of our 
study was limited to 87 days, and therefore it is possible 
that additional parasite recrudescence phases may have 
been missed. In addition, all infections were composed of a 
single P. chabaudi clone, whereas, in a recent study of P. 
chabaudi, infections consisting of three clones were found 
to persist longer than did single-clone infections (De Roode 
et al., 2003). 
The techniques presented here allow a range of hypothe-
ses to be tested. For instance, chronic persistence of malaria 
infections in the face of sustained immune attack is proba-
bly due to antigenic variation by parasites (Phillips et al., 
1997). Antigenic variation is often viewed as an adaptation 
to enhance transmission (e.g., Antia et al., 1996). Tech-
niques such as that presented here make it possible to deter -
mine when transmission stages are present in chronic 
infections, and hence the extent to which antigenic varia-
tion can actually contribute to parasite fitness. Of greater 
practical significance to malaria epidemiology are the find-
ings that chemotherapy led to increased rates of gametocy-
togenesis in acute infections of P. chabaudi and increased 
gametocyte density in infections of P. falciparum (Ali et al., 
2005; Buckling et al., 1997, 1999a,b); if the same occurs in 
chronic asymptomatic infections, inappropriate drug use 
could enhance malarial transmission. Moreover, multi-
clone infections are the rule rather than the exception in 
malaria (Awadalla et al., 2001; Babiker and Walliker, 1997). 
The dynamics of individual clones in mixed infections is 
complex (Bruce et al., 2000; De Roode et al., 2005; Read 
and Taylor, 2001) and the transmission consequences of 
these dynamics are very poorly understood. We are cur-
rently developing allele-specific gametocyte qRT-PCR, 
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which will make it possible to track gametocyte densities of 
individual clones in multiple-clone infections. Such studies 
will shed more light on the dynamics of malaria parasites 
and assess biological and environmental factors that influ-
ence their gametocytogenesis in nature (Bousema et al., 
2004; Price et al., 1999). Gametocyte-specific quantification 
thus makes it possible to conduct detailed studies of 
malaria transmission biology and should help to improve 
predictions of malaria parasite responses to control 
measures. 
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Figure 2b.2: All Mice From experiment 2. Legend as in figure 2 within the manuscript. 
